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The COVID-19 pandemic affected the planning and completion of the Major 
Research Project (MRP; Chapter 2). Due to pandemic related restrictions, the 
original intended project could not proceed as planned and appropriate 
adaptations were made.  
There were no significant changes to the nature of the data collected from the 
two groups of participants recruited (i.e. patients and clinicians), but 
questionnaires were updated to include items of interest, related to COVID-19. 
The mode of assessment changed for patients only. It was originally planned 
that patients would complete study procedures in a face-to-face appointment 
with the researcher. However, due to restrictions on face-to-face contact, 
patients were instead asked to complete the questionnaire independently and 
were given the option of doing so electronically or using paper copies sent in 
the post. Furthermore, restrictions on research activity within NHS Scotland 
during the first COVID-19 lockdown delayed the process of getting ethics and 
R&D approval. This resulted in a considerably shorter recruitment period (6 
weeks rather than the planned 7 months), and thus a smaller sample size was 
achieved than planned. 
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Background: The COVID-19 pandemic and related public health 
measures resulted in many services shifting to remote delivery of psychological 
therapies (i.e. delivery via telephone or video calls). Judging the ‘effectiveness’ 
of delivering psychological therapies to older adults (OAs) in this way, requires 
an understanding of how efficacy and effectiveness have been operationalised 
in previous research.  
Aims: To describe and critically analyse the outcome measures that 
have been used to evaluate the efficacy/effectiveness of psychological 
therapies delivered remotely to OAs, in order to determine whether conclusions 
about efficacy/effectiveness depend on the outcome measure used. 
Method: CINAHL, Psychological and Behavioural Sciences Collection, 
PsycINFO, Journals@Ovidfulltext and Medline were systematically searched in 
January 2021 to identify papers that empirically assessed the 
efficacy/effectiveness of psychological therapies delivered remotely to OAs. The 
CTAM was used to evaluate methodological quality of the included papers and 
their findings were integrated using narrative synthesis. 
Results: Across the 19 included papers a wide range of clinical and 
process outcomes were used to assess efficacy/effectiveness. Synthesis of the 
strengths and weaknesses of primary outcomes of interest (i.e. depression, 
anxiety, functioning and process outcomes) highlighted issues with how these 
outcomes have been operationalised and the psychometric properties of certain 
measures with OAs.  
Conclusion: There is no ‘gold standard’ way of measuring clinical or 
process outcomes with OAs and it is likely that conclusions about 
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efficacy/effectiveness of remotely delivered psychological therapies with OAs 
are strongly influenced by the measure used to assess outcome.  
 





Prior to the COVID-19 pandemic, telemedicine was an expanding area of 
research due to technological advances and its potential to reduce access to 
care barriers (Richardson et al., 2009). The COVID-19 pandemic saw the 
introduction of infection control measures, which led to unprecedented changes 
in how NHS services were delivered. Most psychology services shifted to 
remote, digital delivery of psychological therapies (i.e. delivery via telephone or 
video calls) to ensure continuity of service for patients with mental health 
problems. This resulted in increased interest in understanding patient 
preferences for, and the efficacy (i.e. performance under ideal, controlled 
conditions) and effectiveness (i.e. performance under ‘real life’ clinical 
conditions) of remotely delivered psychological therapies. However, this 
literature is severely limited and gaps in our understanding need to be 
addressed to determine how and whether this delivery method should continue 
beyond current crisis measures. In particular, good quality evidence is required 
to make informed choices about the effectiveness of delivering psychological 
therapies to specialist groups, such as older adults (OAs), in order to navigate 
the projected move towards delivering services remotely.  
Tele-medicine 
A review by Richardson et al. (2009) evaluated the various outcomes of 
tele-mental health research conducted between 2003 and 2008. Tele-mental 
health was defined as the delivery of mental health services using video-
conferencing, although authors recognised that a wider definition would include 
telephone, internet and email delivery. Most of the 148 papers reviewed were 
feasibility studies, although six randomised controlled trials (RCTs) were 
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included. This review found that patients from a range of clinical populations 
and services rated tele-mental health acceptable and satisfactory, though it was 
not clear how these constructs were operationalised or if ratings would remain 
high in the presence of alternatives (e.g. in-person delivery). Furthermore, the 
review argued that studies often overemphasized the significance of process 
outcomes, equating them to clinical effectiveness. When clinical outcomes were 
measured in the reviewed studies, tele-mental health was found to be at least 
as efficacious as face-to-face services. However, reviewed studies with OAs as 
the target population were limited to diagnosing dementia and the assessment 
of cognitive functioning, rather than the delivery of psychological therapies. 
A more recent Cochrane review explored the effectiveness, acceptability 
and cost of telemedicine, more broadly, when compared to usual care (Flodgren 
et al., 2015). Similar to Richardson et al. (2009), authors narrowly defined 
telemedicine as delivery via video-conferencing, whereas usual care included 
face-to-face and telephone consultations. Only 7 of the 93 RCTs reviewed 
focused on mental health or substance abuse difficulties. Overall, the review 
suggests that psychological therapies delivered over video-conferencing were 
as effective as face-to-face delivery.  
Tele-medicine with OAs 
 Delivering healthcare remotely to OAs could overcome access to care 
barriers commonly experienced by this demographic, such as difficulties 
attending face-to-face appointments due to transportation difficulties, reduced 
mobility or increased frailty (Woodall et al., 2010). Furthermore, research into 
the effects of COVID-19 related public health measures (i.e. social distancing 
and self-isolation) predicted significant mental health implications for OAs, 
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which may increase their need for mental health support during and following 
the pandemic (BPS, 2020). Therefore, offering OAs the option of receiving 
psychological therapy via remote-delivery digital means would allow them to 
access this support without unnecessary exposure to the virus. Technology 
adoption among OAs has improved in recent years, but evidence suggests they 
remain disproportionately affected by digital exclusion (Anderson & Perrin, 
2017). Multiple factors may affect OAs’ abilities and/or willingness to engage 
with telemedicine, including communication needs (i.e. sensory, motor and/or 
cognitive impairments), limited access to technology and/or lack of confidence, 
knowledge and experience of using interactive technology (Lam et al., 2020; 
Stronge et al., 2007). 
Despite their unique barriers to engagement with technology, literature 
on the use of telemedicine with OAs is lacking, but some evidence does exist. A 
systematic review by Batsis et al. (2019) examined the feasibility, acceptability 
and effectiveness of using telemedicine (defined as two-way video-
conferencing) to deliver medical interventions to OAs. They reviewed 17 RCTs 
and concluded that telemedicine was feasible for use with and acceptable to 
OAs, and results in similar outcomes to in-person delivery. However, authors 
noted that the methodological quality of the reviewed studies was poor, and the 
interventions delivered only targeted specific physical health conditions. There 
is a high prevalence of mental health difficulties in the OA population (Andreas 
et al., 2017), yet no systematic review to date has focused on evaluating the 
efficacy/effectiveness of remotely delivered psychological therapies with OAs’ or 
their preferences for this. Therefore, the data in this area needs to be 
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synthesized to ensure the provision of high-quality, evidence-based services to 
OAs with mental health problems, in line with NHS objectives. 
A starting point for making judgements about ‘effectiveness’ is to 
understand how it has been operationalised in previous research. This 
systematic review aims to address this issue by examining the outcome 
measures that have been used in research to evaluate the 
efficacy/effectiveness of remotely delivered psychological therapies for treating 
mental health problems in OAs. It is hoped that this new understanding will 
highlight any potential difficulties of drawing conclusions about 
efficacy/effectiveness, which will help services decide whether to continue 
delivering psychological therapies remotely to OAs. 
Research Questions 
1. What outcome measures have been used to evaluate the 
efficacy/effectiveness of psychological therapies with OAs delivered 
remotely via telephone or video calls?  
2. What are the strengths and weaknesses of commonly used outcome 
measures? 
3. Do conclusions about efficacy/effectiveness depend on the outcome 
measure used?  
METHODS 
This systematic review followed PRISMA reporting guidance (Moher et 
al., 2009). These eligibility criteria were applied: 
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Inclusion Criteria 
• Treatment studies including RCTs, quasi-experimental studies and single 
group treatment trials that measured outcome(s) pre- and post-intervention. 
• OA participants (mean sample age ≥60) or studies that stratify by age. 
• Individual psychological therapy targeting mental health 
problems/symptoms. 
• Telephone or video-call delivery, with real-time clinician-patient interaction. 
Video-calls are considered the best alternative to face-to-face delivery, as 
they provide verbal and non-verbal information (Nieman & Oh, 2020), but 
telephone interventions were also included as they are more accessible to 
OAs (Lam et al., 2020). 
• Empirical outcomes measured and method of assessment described. 
• Published in English.  
Exclusion criteria 
• Single case studies, dissertations, review or discussion papers, books and 
book chapters. 
• Psychological therapies targeting substance-abuse, physical health 
problems and/or lifestyle health behaviours. 
• Interventions delivered to caregivers, unless directly targeting caregivers’ 
mental health difficulties.  
• Non-psychological mental health interventions (e.g. using digital technology 
for reviewing and revising medications) 
• Interventions delivered in-person or by other digital/remote methods, 
including email, text messaging, mobile-apps or web-based interventions 
(e.g. Computerised Cognitive Behavioural Therapy). These delivery 
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methods are less suited for high-intensity or specialist psychological 
therapies, like those delivered to OAs (NES, 2015), given their limitations for 
recognising and managing risk and significant emotional distress.    
Search Strategy 
A systematic search of six electronic databases was conducted in 
January 2021 (no date restrictions applied): EBSCOhost - CINAHL, 
Psychological & Behavioral Sciences Collection and PsycINFO; Ovid - 
Journals@Ovidfulltext and Medline; and Cochrane Library.  
Three groups of search terms were applied for each database, pertaining 
to: OAs, psychological therapies, and remote delivery methods (see Appendix 
1.2 for an example of the search terms applied). Truncation and Medical 
Subject Headings were used where applicable, and results were combined 
using the Boolean operators ‘OR’ (within groups) and ‘AND’ (between groups).  
Screening 
Search identified citations were exported to EndNote X9 and duplicates 
removed. Titles and abstracts were screened for relevance. Full-texts of 
remaining papers were evaluated for eligibility by the author. A second reviewer 
(HM) screened a subset of papers and disagreements were resolved through 
discussion. Authors were contacted for two electronically inaccessible papers, 
but neither responded. Forward and backward citations of eligible papers were 
hand searched.  
Data Extraction and Synthesis 
Included papers were heterogeneous in nature, consequently narrative 
synthesis was identified as the most appropriate means of summarising and 
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integrating their findings (Grant & Booth, 2009). Popay et al. (2006) outlined key 
elements involved in narrative synthesis, which this review followed: 
Preliminary synthesis of findings 
The author extracted key information from the included papers into tables 
developed for this purpose (i.e. Tables 1 and 2).  
Explore relationships in the data 
Key study characteristics were explored to identify relationships between 
the papers in relation to the review questions.  
Assess the robustness of the synthesis  
The review questions were addressed and any difficulties drawing 
conclusions from the included papers’ findings were highlighted. 
Quality Appraisal 
Methodological quality of the papers was evaluated using the Clinical 
Trial Assessment Measure (CTAM; Tarrier & Wykes, 2004). The CTAM was 
chosen because its six subscales address different design features highlighted 
in the CONSORT guidelines (Moher et al., 2003) as important for the validity of 
psychological therapies studies. These subscales are individually scored and 
contribute a different weighting towards an overall quality score for the paper 
(maximum of 100). The CTAM was developed for evaluating RCTs, but has 
been used with other study designs (e.g. Swan et al., 2017). Wykes et al. 
(2008) found it to be a reliable and valid measure, and selected scores of ≥65 to 
indicate adequate methodological quality.  
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The author rated all papers, and four papers (>20%) were second rated 
by an independent reviewer (DT). The concordance rate was 84% 
(discrepancies were resolved through discussion). 
RESULTS 
The search identified 1831 citations (once duplicates were removed). 
Title and abstract screening resulted in 136 papers and 117 of these were 
excluded after full-text screening (62% did not meet inclusion criteria for age). 
Nineteen papers fulfilled the eligibility criteria (see Figure 1): fifteen RCTs, one 
non-RCT and three case study series. Key paper characteristics are 
summarised in Table 1. 
Sample Characteristics 
Eight papers used the same sample as at least one other paper. 
Therefore, the 19 papers only represent 14 studies. A total of 2083 participants 
were included in this review, with a weighted mean age of 65.5 years 
(range=23-89); 78% of participants were female. Type and severity of 
participants’ presenting mental health problems varied across papers, as did 
whether clinical levels were required for inclusion.  
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Figure 1: PRISMA Flow Diagram 
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• CBT-T had 
significantly greater 
decline in worry, GAD 
and depression. 
• Significant decline in 
general anxiety in both 
groups. No significant 
group difference. 






































Same as Brenes et al. (2015); Brenes et al. (2017).  ISI, SF-
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 • Significantly greater 
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insomnia and QoL in 
CBT-T. Insomnia 
gains maintained at 
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anxiety in both groups. 





































• Significantly greater 
improvements in 
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  • Emotional well-being 
improved significantly 
more in CBT-T vs. 
controls.  
• Body complaints 
reduced significantly 
in CBT-T vs. untreated 
control.  






























Criteria* Primary Secondary Process 
• Significant worsening 










































 • CBT-T had 
significantly improved 
emotional wellbeing, 
fewer body complaints 
and reduced 
depression vs. TAU.  
• Emotional well-being 





































• Participant 1: non-
significant reduction in 
depression. No 
change in anxiety. 
• Participant 2: no 
significant change in 
depression. Clinically 
significant reduction in 
anxiety. 
• Participant 3: clinically 
significant reduction in 
depression. Non-





















Criteria* Primary Secondary Process 
• Positive feedback re: 
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• Significantly reduced 
depression in CBT-T. 
Gains maintained at 
one-month follow-up. 
Non-significant 
reduction in anxiety. 
• Anxiety significantly 
worsened in WLC 
from baseline to 
follow-up. 
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maintained for all. 
Change clinically 
significant for one 
participant. 





















Criteria* Primary Secondary Process 
• All ‘satisfied’ or ‘very 
satisfied’ with VC.  
Lichstei











































• Treatment procedures 
“clear” or “very clear”. 


































 TEI • Tele-PST reported 
significantly higher 
acceptance than in-
person PST.  
• Significantly lower 
depression in PST 
groups than TS at 12- 
and 24-week follow-
up. 









































































 • Significantly lower 
depression and 
disability scores in 
PST groups vs. TS at 
12- and 24-weeks. 
Difference only 
significant for Tele-
PST at 36-weeks. 
• No significant 
differences between 
PST conditions at 12- 
and 24-weeks, but 
Tele-PST depression 
scores significantly 
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  • Tele-PST had 
significantly lower 
suicidal ideation 
ratings than TS across 
follow-ups.  
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GDS, BDI  • Tele-BA non-inferior to 
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• Depression improved 
significantly in both 


















• Significant group 
difference in QoL at 
12-month follow-up 
only.  
• No other significant 
group differences.  
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*See Table 3 for details of outcome measures 



















Criteria* Primary Secondary Process 
Abbreviations: RCT, Randomised controlled trial; CBT, Cognitive Behavioural Therapy; CBT-T, telephone-delivered CBT; M, mean; SD, standard 
deviation; GAD, Generalised Anxiety Disorder; PD, Panic Disorder; ADNOS, Anxiety Disorder Not Otherwise Specified; SCID, Structured Clinical Interview 
for DSM-IV; DSM-IV, Diagnostic and statistical manual of mental disorders (American Psychiatric Association, 2000); NST-T, telephone-delivered non-
directive supportive therapy; HS, High Scool; GED, Graduate Equivalency Degree; QoL, Quality of Life; PMR, Progressive Muscle Relaxation; TAU, 
Treatment as usual; HADS, Hospital Anxiety and Depression Scale; WLC, Wait-list control; VC, video-conferencing; Tele-, VC delivery; BA, Behavioural 




Table 2: Outcome measures used in the included papers 
Name (Citation*) 
Scale 
Abbreviation Outcome Type 
Description 
of Measure 





Papers Adequate Inadequate 
Not 
Reported 
Mental Health Outcomes 
Allgemeine 
Depressionsskala 
(Hautzinger et al., 
2012) 
ADS Depression 20-items 
Self-report 
  ü Adults: 0.89-0.92 2 
Anxiety Sensitivity 
Index (Peterson & 
Reiss, 1992) 




ü   OAs: 0.89 
(Brenes et al., 2012). 
1 
Beck Anxiety 
Inventory (Beck et 
al., 1988) 
BAI Anxiety 21-items 
Self-report 
ü   OAs: 0.9 




Inventory (Beck et 
al., 1979) 
BDI Depression 21-items 
Self-report 
ü   OAs: 0.86-0.91 
(Beck & Steer, 1987). 
5 
Consensus Sleep 




Self-report   ü  1 
Geriatric Anxiety 
Inventory (Pachana 
et al., 2007) 
GAI Anxiety 20-items 
Self-report 
ü   OAs: 0.91-0.93 1 
Generalised Anxiety 
Disorder scale 7-item 
(Spitzer et al., 2006) 
GAD-7 GAD symptoms 7-items 
Self-report 





Sheikh & Yesavage, 
1986; Yesavage et 
al., 1982) 








HAM-A Anxiety 14-items 
Interviewer-
rated 




Abbreviation Outcome Type 
Description 
of Measure 

























Index (Morin, 1993) 
ISI Insomnia 7-items 
Self-report 
ü   OAs: 0.86 




Scale (Watson et al., 
1988) 
PANAS Overall mood. 20-items 
Self-report 
  ü Adults: 0.85-0.89 














  ü Adults: 0.93 1 
Patient Health 
Questionnaire (-8: 
Kroenke & Spitzer, 
2002; -9: Kroenke et 
al., 2001) 





  ü PHQ-9, adults: 0.89 2 
Penn State Worry 
Questionnaire 
(Abbreviated) (Meyer 








ü   16-item, OAs: 0.75 
(Brenes et al., 2012) 
8-items, OAs: 0.89 














 OAs: 0.51 





Abbreviation Outcome Type 
Description 
of Measure 





Papers Adequate Inadequate 
Not 
Reported 







Other Patient Outcomes 
Gießen Body 
Complaints List 
(Brähler et al., 2008) 




  ü Adults: 0.94 2 
Pepper Center Tool 
for Disability (Rejeski 







ü    1 




(Ritsner et al., 2005) 
Q-LES-Q-18 QoL 18-items 
Self-report 
  ü Adults: 0.74-0.94 1 
Short-form Health 
Survey (Ware et al., 
1993). 
SF-36 QoL 36-items 
Self-report 
ü   OAs: 0.80 











  ü  2 
WHO Quality of Life 










(Larsen et al., 1979) 




ü   OAs: 0.94 





Abbreviation Outcome Type 
Description 
of Measure 












(Pellegrin et al., 
2001) 




  ü Adults: 0.96 1 
Treatment Credibility 
Questionnaire 
(Borkovec & Nau, 
1972) 














  ü OAs: 0.82 




(Tracey & Kokotovic, 
1989) 
WAI-S Strength of WA 





  ü OAs: 0.84-0.85 





(Tichenor & Hill, 
1989) 
WAI-O Strength of WA 12-items 
Observer-
rated 
  ü Adults: 0.98 1 
*Reference for internal consistency, unless otherwise specified. 
**As reported in reviewed papers. Includes different types of reliability and/or validity. Correlation coefficients ≥0.7 deemed adequate.  
***As reported in reviewed papers. Cronbach’s α scores ≥0.7 deemed adequate. 






Total quality scores varied considerably across studies (range=16-83; 
see Table 1), which is partially attributable to study design. Case series and 
non-RCTs generally received lower scores, but there was also variation 
between RCTs (range=23-83). Papers that reported different outcomes for the 
same study received different scores (e.g. Brenes et al., 2016, 2017; Brenes et 
al., 2015), which suggests an issue with inadequate reporting and could explain 
some of the variance. 
Five of the included papers were considered to have adequate 
methodological quality (score ≥65). However, caution is required when applying 
this arbitrary cut-off as the papers scored low on particular subscales (see 
Appendix 1.3 for CTAM subscale scores). Three of these papers assessed the 
efficacy of telephone-delivered CBT (CBT-T) for treating anxiety and depression 
in OAs (Brenes et al., 2017; Brenes et al., 2015; Doyle et al., 2017), whereas 
two assessed the efficacy of Behavioural Activation (BA) delivered over video-
calls (Tele-BA) for treating depression in OAs (Egede et al., 2015; Egede et al., 
2016). Overall, these papers’ findings support remote delivery of psychological 
therapies to OAs, with few exceptions (see Table 1). However, they used 14 
different standardised measures to assess common outcomes (i.e. depression, 
anxiety and satisfaction) and only nine of these have been validated with OAs. 
Outcome Measures 
Outcomes measured across the papers varied, and all used multiple 





The most reported mental health outcomes were depression and anxiety. 
The most frequently used measure of depression was the Hamilton Rating 
Scale for Depression (HAM-D) (Hamilton, 1960). Two versions of HAM-D were 
used: the original 17-item version, without its four supplementary items; and a 
24-item version, which incorporates three psychological symptoms of 
depression (hopelessness, helplessness and worthlessness). The Beck 
Depression Inventory (BDI; Beck et al., 1979) was the second most frequently 
used measure of depression and was used in two higher quality papers (Brenes 
et al., 2015; Egede et al., 2015). It focuses more on the psychological 
symptoms of depression when compared with HAM-D, which puts greater 
emphasis on somatic symptoms.  
Similar to depression, the measures used to assess anxiety 
operationalised the construct differently. For example, the most frequently used 
measure of anxiety, the Hamilton Anxiety Rating Scale (HAM-A; Hamilton, 
1959), mainly focuses on somatic symptoms, whereas the State-Trait Anxiety 
Inventory-Trait (STAI-T) excludes them completely. The HAM-D and HAM-A are 
both interviewer-rated measures, but most measures used in the studies were 
self-report (83%).  
Seven papers assessed non-mental health patient outcomes, including: 
quality of life (QoL) and disability/functioning. Measures of these constructs 
often overlap in content. For example, QoL was most commonly measured 
using the short-form health survey (SF-36; Ware et al., 1993), which assesses 




measures of disability, such as the World Health Organisation (WHO) Disability 
Assessment Schedule (WHODAS II; WHO, 2000). 
Process Outcomes: 
Nine papers assessed process outcomes in some format. Two 
standardised measures of satisfaction were used: The Client Satisfaction 
Questionnaire (CSQ; Larsen et al., 1979) and the Charleston Psychiatric 
Outpatient Satisfaction Scale (CPOSS; Pellegrin et al., 2001). The CSQ 
assesses participant satisfaction with treatment (e.g. length, quality and 
outcome) and was used in two higher quality papers (Brenes et al., 2015; Doyle 
et al., 2017). The CPOSS was used by one higher quality paper (Egede et al., 
2016) and assesses participant satisfaction with service (e.g. waiting room 
appearance, clinic location and parking). CPOSS items are likely less relevant 
to remotely delivered services.  
Six papers developed non-standardised questionnaires to assess 
process outcomes, and it was often unclear how they defined acceptance 
and/or satisfaction as they merely asked, “how acceptable was this treatment?” 
(e.g. Wuthrich & Rapee, 2019) or “how satisfised were you with video-
conferencing?” (e.g. Lazzari et al., 2011).  
DISCUSSION 
This review aimed to describe and critically analyse the outcome 
measures that have been used to evaluate the efficacy/effectiveness of 
psychological therapies remotely-delivered to OAs, in order to assess their 





Heterogeneity in outcome measurement makes it difficult to compare 
across studies and this review has insufficient scope to critique the strengths 
and weaknesses of each measure. Harmonisation of outcome measurement is 
a challenge that extends across mental health science (Wolpert, 2020). To 
address this issue, the Wellcome Trust have introduced a core set of measures 
for use in mental health research with adults: Patient Health Questionnaire 
(PHQ-9) for depression; Generalised Anxiety Disorder scale (GAD-7) for anxiety 
and WHODAS for impact on functioning (Farber et al., 2020). In line with this 
approach, this review uses depression, anxiety and functioning as examples of 
commonly reported outcomes, to address the research questions. Process 
outcomes are also considered as we are interested in how OAs receive 
treatments and their preferences.  
Depression 
Measures varied in how they operationalised depression and placed 
greater weighting on different symptoms (e.g. somatic vs. psychological 
symptoms). The reviewed papers justified their use of different measures. For 
instance, Lazzari et al. (2011) argued that depression tends to be expressed 
more somatically in OAs than in younger adults, but other papers argued that 
psychological symptoms are more sensitive to depression in OAs (Moberg et 
al., 2001). This lack of consensus about how depression presents in OAs would 
benefit from further research. 
Although HAM-D was the most frequently used measure of depression, it 
was not used by the four higher quality papers that targeted depression. Brenes 




compared to telephone-delivered non-directive supportive therapy (NST-T), but 
Brenes et al. (2017) found no significant group difference at 15-month follow-up. 
Egede et al. (2015) used the BDI and the Geriatric Depression Scale (GDS; 
Yesavage et al., 1982) to assess the comparative effects of Tele-BA and in-
person BA. They found significant improvements in depression in both groups 
across follow-ups and concluded that Tele-BA was non-inferior to in-person BA. 
Using both the BDI and GDS to measure depression may improve the validity of 
these results, as when combined, these measures encompass more symptoms 
of depression. Furthermore, both measures have been found to have adequate 
internal consistency with OAs.  
Doyle et al. (2017) was the only paper to use the Wellcome Trust’s 
mandated measure of depression, PHQ-9. They compared CBT-T to 
befriending and found significant improvements in depression in both groups at 
post-intervention, but gains were only maintained for CBT-T at follow-up. The 
PHQ-9 has been found to have adequate internal consistency in the general 
adult population, but its psychometric properties with OAs are unknown. 
Furthermore, it is a relatively short measure and thus captures limited 
information about participants’ difficulties (Fried, 2017).  
Anxiety 
Similar to depression, measures of anxiety operationalised the construct 
differently, putting greater emphasis on different symptoms. Two higher quality 
papers, Brenes et al. (2015) and Brenes et al. (2017) used HAM-A and GAD-7 
to assess the effectiveness of CBT-T, compared to NST-T, and found different 
outcomes across the different measures (i.e. significant group difference for 




reversed at 15-week follow-up). Doyle et al. (2017) was the only other higher 
quality paper that assessed anxiety. They used the Beck Anxiety Inventory  
(BAI; Beck et al., 1979) to measure the effectiveness of CBT-T compared to 
befriending and found that only befriending resulted in significant improvements 
in anxiety at post-intervention and follow-up.  
The variation in these results demonstrates how measures introduce 
bias, which affects interpretations about the efficacy of CBT-T in reducing 
anxiety. For instance, variations in findings could be attributed to how measures 
operationalise anxiety and/or their different psychometric properties. The BAI 
and HAM-A have been validated with OAs and shown adequate internal 
consistency, but the internal consistency of GAD-7 with OAs is unknown. 
Findings from these studies would benefit from replication with more 
established control groups (e.g. in-person delivery of the psychological therapy 
as the comparator). 
Functioning 
Despite functioning being recognised as a primary outcome for mental 
health research, it was only measured by three papers, all deemed to have 
inadequate methodological quality. Brenes et al. (2016) used the Pepper Center 
Tool for Disability (PCT-D; Rejeski et al., 2008) and found no difference 
between CBT-T and NST-T groups at post-intervention. However, Choi et al. 
(2014b) and Choi et al. (2020) used WHODAS and found significant 
improvements in functioning in Tele-BA and Problem Solving Therapy, 
delivered in-person and over video-calls, when compared to telephone-support. 
While the WHODAS has been widely validated (Üstün et al., 2010), the 




Therefore, caution is required when interpreting these positive results, and they 
would benefit from replication using a measure of functioning validated with 
OAs, such as the PCT-D.  
Process 
There seems to have been a shift in how process outcomes are 
measured in research, with a higher proportion of papers in the present study 
using standardised measures than in Richardson et al. (2009). However, similar 
to findings in Richardson et al. (2009), six papers developed non-standardised 
measures to assess process outcomes and it was often unclear how these 
papers had defined satisfaction or acceptance. This limits the ability to make 
valid and meaningful comparisons across studies (Larsen et al., 1979).  
Participant ratings of acceptance and satisfaction were ‘high’ across 
papers, regardless of the method used to assess them. These findings are likely 
impacted by social desirability bias, which questions their significance (Larsen 
et al., 1979). Furthermore, the papers that measured acceptance or satisfaction 
with treatment only did so in the group receiving psychological therapy remotely 
or in comparison to a less established control. Therefore, it is unknown whether 
ratings would remain ‘high’ if other options were available (e.g. if participants 
were offered a choice between remote or in-person therapy). This would be a 
valuable area for future research, given previous findings that accommodating 
patient preferences for psychological therapy can improve adherence and 
outcomes (Swift et al., 2018).  
Overall, this review highlights the challenges of defining mental health 
outcomes and suggests that outcome measures do impact the interpretation of 




given the breadth and complexity of the outcomes being assessed, there is no 
‘perfect’ measure. Attempts to standardise outcome measurement across 
mental health research (i.e. Wolpert, 2020) goes some way to resolving the 
difficulties faced in this review when attempting to compare findings across 
papers. However, such an approach raises the problem of the most widely used 
measure becoming ‘gold standard’, when it may not be the most appropriate. 
This was the case for the mandated measures in this review, given their 
psychometric properties with OAs are unknown. Furthermore, Patalay and Fried 
(2020) argued that this approach could discourage the measurement of other 
clinically meaningful outcomes or disregard meaningful findings from other 
measures.  
Strengths and Limitations 
A strength of this review is that it is the first to synthesise data relating to 
outcome measurement in psychological therapies efficacy research with OAs. 
While every effort was made to carry out a systematic and thorough literature 
search, limiting it to papers published in English and peer-reviewed journals 
may have excluded relevant papers and introduced publication bias. The 
exclusion of digital delivery methods other than telephone or video calls may 
also have excluded relevant papers with clinically meaningful findings.  
Additionally, the selection of the CTAM for assessing methodological 
quality may have introduced further bias. The CTAM was developed for 
evaluating RCTs, and it could be argued that grading other study designs to the 
same standard is unfair. However, for mental health research findings to 
appropriately inform policy and practice, studies with adequate methodological 




appraisal process was largely completed by a sole researcher, which introduces 
subjectivity to CTAM scores. To limit possible experimenter bias, >20% of 
papers were second rated by an independent researcher. Also, due to 
difficulties comparing across papers and having no standardised way of 
weighting findings based on CTAM scores, this review focused on the higher 
quality papers for brevity. This may, however, have disregarded clinically 
meaningful findings in papers rated lower in quality.  
Implications 
Given the majority of the included papers had poor methodological 
quality and issues with sample representativeness, clinicians working with OAs 
need to be cautious about assuming the efficacy/effectiveness of remotely 
delivered psychological therapies. Many of the reviewed papers included 
participants younger than 60 years and with sub-clinical levels of mental health 
difficulties. Samples were also majority female and sample race/ethnicity was 
either not reported or lacked diversity. The latter is a significant limitation of this 
research given the disproportionate impact of digital poverty within Black, Asian 
and Minority Ethnic groups (Zhai, 2021). Furthermore, the included papers 
focused on treating anxiety and/or depression, and excluded participants 
presenting with multi-morbidity, suicidal ideation and/or less prevalent mental 
health difficulties, such as psychosis. Therefore, this review highlights a gap in 
the literature, which has significant implications for clinicians delivering 
psychological therapies remotely to this demographic.  
Future research addressing these limitations and using outcome 
measures that have been standardised with OA clinical populations is required. 




have been operationalised, a useful line of subsequent enquiry could be an in-
depth critical analysis at component level of mental health outcome measures. 
This would support identification of a core set of measures for use in mental 
health research with OAs and would allow more meaningful conclusions about 
the efficacy of psychological therapies with OAs to be drawn.  
This review also has implications for implementation science theory (e.g. 
Bauer et al., 2015), as it highlights a research-to-practice gap that needs to be 
addressed to support psychological services to adjust from face-to-face to 
remote/digital delivery. Tele-mental health research would benefit from 
implementation issues being considered earlier in the research process, so that 
further research is more aware of clinical contexts and thus more generalisable. 
To inform this process, MRC guidance on developing and evaluating complex 
interventions (Moore et al., 2015) could be followed.  
Conclusion 
There is currently no ‘gold standard’ way of measuring the 
efficacy/effectiveness of remotely delivered psychological therapies for OAs. 
Although there are some promising findings across the reviewed papers, given 
the discussion here about relative strengths and weaknesses of the various 
outcome measures used, and other methodological limitations across the 
papers, it is too early to conclude the efficacy/effectiveness of remotely 
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Plain Language Summary 
Title: A feasibility study examining treatment and outcome 
preferences of older adults (OAs) with mental health difficulties 
during COVID-19 and the effects of preferences on clinician 
decisions about treatment 
 
Background: Research has found that individuals who seek a 
talking therapy to improve their mental health have preferences 
about what they want therapy to involve (i.e. treatment preferences) 
and what they hope to gain from therapy (i.e. outcome preferences). 
However, there is no agreed upon method for eliciting preferences 
and research has found that therapists (from here on referred to as 
clinicians) do not always consider preferences when deciding which 
treatment approach would best address each individual’s mental 
health needs (Stewart et al., 2018).   
 
Aims: This study investigated the use of questionnaire methods for 
finding out 1) OAs’ treatment and outcome preferences, and 2) if 
clinicians consider OAs’ preferences when making decisions about 
treatment. We also aimed to describe OAs’ and clinicians’ 





Methods: Two questionnaires were adapted from previous research 
for use in this study. OAs were recruited from NHS Lanarkshire 
Psychological Therapies for Older People service and asked to 
complete a questionnaire about their preferences for therapy (the 
Patient Preferences Questionnaire, PPQ). Clinicians who provide 
talking therapies to OAs were also recruited and asked to complete 
a questionnaire about their decision-making (the Clinicians Decision-
Making Questionnaire, CDMQ). To assess how ‘acceptable’ each 
questionnaire was, participants were asked to give feedback about 
the length of the questionnaire, and whether the questions they 
were asked made sense and were relevant to them.  
 
Main Findings: 18 OAs and 27 clinicians were recruited and 
completed the questionnaires. Both groups rated the questionnaires 
as ‘acceptable’. OAs expressed a preference for therapy delivered 
in-person, rather than over video call. They also preferred to ‘learn 
ways to be less self-critical’ and to ‘feel more confident’ following 
therapy. Clinicians rated their own experience of delivering talking 
therapies to OAs as the factor that influenced their decision-making 
about treatment the most. They also considered OAs’ preferences 




as having the most influence on whether they incorporated OAs’ 
preferences when making decisions were OAs’ understanding of 
their mental health needs (i.e. insight), and if the OA had previous 
experience of receiving a talking therapy. Clinicians also stated that 
COVID-19 made it more difficult for them to accommodate OAs’ 
preferences.   
 
Conclusions: This study supports the use of questionnaires to find 
out about OAs’ treatment and outcome preferences and gather data 
from clinicians about their decision-making. However, the sample 
was small and did not represent all OAs who may seek a talking 
therapy to improve their mental health. This limitation means caution 
should be used when interpreting questionnaire responses. Future 
research replicating the study with a larger, more representative 
sample would allow more meaningful conclusions to be drawn.  
 
Key Reference: Stewart, R. E., Chambless, D. L., & Stirman, S. W. 
(2018). Decision making and the use of evidence-based practice: Is 





Background: Evidence-based practice requires using the best research 
evidence, clinical expertise, and patient characteristics/preferences to inform 
the provision of appropriate interventions. Although accommodating patient 
treatment preferences can have a significant positive impact on psychotherapy 
attendance and outcome, they are often overlooked in clinical decision-making. 
Aims: To establish the feasibility and acceptability of using self-report 
questionnaires to elicit older adults’ (OAs) mental health treatment and outcome 
preferences and determine whether clinicians consider these preferences when 
selecting treatment. The secondary aim is to establish a preliminary 
understanding of participants’ responses on the questionnaires.  
Methods: Two questionnaires were adapted from previous research for 
this study. Patients were recruited from NHS Lanarkshire Psychological 
Therapies for Older People service and asked to complete a questionnaire 
about their preferences for psychological therapy. Clinicians who deliver 
psychological therapies to OAs were recruited and asked to complete a 
questionnaire about their decision-making. Participants also rated questionnaire 
acceptability.   
Results: 18 patients and 27 clinicians were recruited. Patients 
expressed preferences for therapy delivered in-person. Their most preferred 
therapy task was ‘learn ways to be less critical of me’ and outcome was ‘feel 
more confident’. Clinicians rated their clinical experience as the most influential 
factor in their decision-making about treatment. They also identified patient 
insight and previous experience of therapy as the factors with the most 




reported that COVID-19 makes accommodating patient preferences more 
difficult.   
Conclusions: questionnaires are a feasible and acceptable method of 
eliciting OAs’ treatment and outcome preferences and gathering data about 
clinicians’ decision-making.  
 
Keywords: Patient preferences, older adults, decision-making, psychological 






The global population is ageing, and the proportion of people aged 60 
and over is projected to double by 2050 (World Health Organisation [WHO], 
2017). Approximately 23% of people in this age range present with a 
diagnosable mental health problem, with the most common difficulties are 
anxiety (11%) and depression (6%; Andreas et al., 2017). Older adults (OAs) 
can experience the same range of mental health difficulties as their younger 
counterparts (Volkert et al., 2013), but their risk factors for developing these 
difficulties may differ. For example, OAs are more likely to experience 
bereavement and/or functional decline (e.g. due to reduced mobility, chronic 
pain or increased frailty; WHO, 2017). Furthermore, the likelihood of 
experiencing multiple co-occurring mental and/or physical health difficulties 
increases with age (i.e. ‘multi-morbidity’; Barnett et al., 2012), and can have a 
significant impact on quality of life, disability status and health care utilization 
(Marengoni et al., 2011). Therefore, OAs are recognised as a complex and 
heterogenous group, but their mental health needs are often overlooked in 
research and under-identified in clinical practice (Marengoni et al., 2011; WHO, 
2017). This has resulted in their mental health difficulties predominantly being 
treated with medication and acts as a barrier to them accessing other 
treatments, such as psychological therapies (Royal College of Psychiatrists, 
2018). Consequently, improving the provision of and access to effective mental 
health treatments for OAs has become a public health priority (WHO, 2017).  
Obstacles to achieving this priority include increasing public expectations 
for healthcare and financial constraints, but changes to healthcare provision, 




barriers (e.g. Scottish Government, 2010). These approaches seek to change 
how services are delivered by introducing shared decision-making, aimed at 
determining what matters most to patients and developing a personalised 
approach to their care. These approaches also uphold the ethical principles of 
peoples’ right to self-determination and autonomy (British Psychological Society 
[BPS], 2018). Mental health services need to adapt to meet the needs of this 
growing demographic and work jointly with patients to offer acceptable and 
beneficial interventions, including psychological therapies.  
Evidence Based Practice (EBP)  
Best practice in the treatment of mental health difficulties requires the 
provision of EBP. However, research describing the importance of delivering 
EBP is limited, and many key references are approximately two decades old 
(e.g. Sackett et al., 2000). Research examining the efficacy of psychological 
therapies for the treatment of mental health difficulties in OAs is also relatively 
limited, when compared to equivalent research with general adult clinical 
populations. To date, most research into the efficacy of psychological therapies 
for OAs has focused on Cognitive Behavioural Therapy (CBT) for depression or 
anxiety, which has been found to be as efficacious as other psychological 
treatments and more effective than waiting list controls (Cuijpers et al., 2009; 
Hofmann et al., 2012). There is also emerging evidence supporting the use of 
other psychological therapies with OAs, including Acceptance and Commitment 
Therapy (ACT; Luci et al., 2016; Wetherell et al., 2011). Having a range of 
empirically supported therapies (ESTs) for OAs, provides room for choice and 
preference accommodation. However, the recent focus on developing ESTs, 




deemphasized the importance of the two other critical components of EBP (as 
defined by Sackett et al, 2000), i.e. clinician expertise and patient preferences 
and values. This may explain the observed gap between research and practice 
(TenHave et al., 2003). 
A small, but significant literature indicates that clinicians discount 
research evidence in favour of using their clinical experience to inform treatment 
decisions (Gyani et al., 2014; Safran et al., 2011; Stewart et al., 2018). 
Clinicians may have valid reasons for their reluctance to implement ESTs, such 
as small, unrepresentative samples in psychological treatment outcome studies 
(Corrigan & Salzer, 2003) and insufficient evidence to inform all treatment 
decisions (Stewart et al., 2018). However, there are well-documented flaws 
associated with clinicians relying solely on their experience when making 
decisions (e.g. Lilienfeld et al., 2013). A recent review of the factors that 
influence decision-making found that none of the surveyed clinicians based 
their treatment decisions on patient preferences (Stewart et al., 2018), despite 
evidence that patients and clinicians have differing views concerning the tasks 
and goals of treatment (Moritz et al., 2017). Therefore, work needs to be done 
to increase clinicians’ awareness of research that highlights the importance of 
incorporating patient preferences when making decisions about their treatment.  
Patient Preferences 
Patient treatment preferences have been defined as ‘the behaviours or 
attributes of the therapist or therapy that a client values or desires’ (Swift et al., 
2011, p. 151), and divided into three categories: therapy tasks, therapy format 
and therapist characteristics (Swift et al., 2018). Treatment preferences are 




of treatment options and subsequently their motivation to change and engage 
(Corrigan & Salzer, 2003). In their recent meta-analysis, Swift et al. (2018) 
found that accommodating client treatment preferences for psychotherapy 
resulted in less drop out and better outcomes. These results were in line with 
previous research (Swift et al., 2011), but some contradictory findings do exist 
(e.g. Leykin et al., 2007). Despite this variability in results, preferences likely 
have an indirect effect on outcome through factors such as engagement, 
adherence, and satisfaction (Winter & Barber, 2013).  
To summarise, there is disproportionate attention given to ESTs in 
research and clinician experience in decision-making, at the expense of patient 
preferences (Stewart et al., 2018), despite findings suggesting they play a 
significant role in therapy attendance and outcomes (Swift et al., 2018). 
However, it is recognised that the literature addressing patient preferences is 
limited, and more recent and robust research is required, for example, to 
determine if existing findings are replicable with different patient groups. To 
date, little attention has been given to patients’ preferred treatment outcomes 
(i.e. what they hope to gain from therapy; Eiring et al., 2015). Furthermore, 
studies have described the relative pros and cons of methods previously used 
to elicit patient preferences, but no preferred method has been identified (Ryan 
et al., 2001; Swift et al., 2018). In their systematic review of techniques used to 
elicit public preferences for healthcare, Ryan et al. (2001) recommended that 
research be carried out to test the available methods. Therefore, we aimed to 
test preference identification methods with OAs and examine if clinicians take 





The Impact of Coronavirus Disease 2019 (COVID-19) 
During the design of this study, COVID-19 was recognised as a global 
pandemic (World Health Organization, 2020) and public health measures, such 
as physical distancing and self-isolation, were introduced to contain the spread 
of the virus. OAs (age 70 and over) were declared a high risk group and 
encouraged to self-isolate following emerging data emphasising their increased 
mortality after contracting COVID-19 (NHS, 2020). According to the BPS’ 
‘Faculty of the Psychology of Older People’ (BPS-FPOP, 2020a), self-isolation 
was predicted to have significant mental health implications for OAs, including 
higher levels of mental distress and loneliness. BPS-FPOP (2020b) argued that 
the effects of self-isolation are more likely to have a detrimental, long-term 
effect on OAs’ mental health the longer these symptoms and isolation persist. 
This view was supported by Brooks et al. (2020) in their review of the 
psychological impact of quarantine. They identified multiple stressors that can 
exacerbate the psychological effects of quarantine, ranging from boredom and 
inadequate information to infection fears and lack of essential supplies. 
Investigating the true impact of COVID-19 on the mental health of OAs is 
ongoing, but it is likely that OAs are experiencing a number of these stressors. 
Therefore, their recent experiences may influence their treatment and outcome 
preferences for psychological therapy in the future. Mental health services need 
to prepare for the most likely eventualities so that they can adequately meet the 
psychological needs of OAs going forward.  
The UK government’s restrictions on face-to-face contact led to the 
implementation of contingency plans within the NHS to ensure clinical contact 




psychological services, this involved switching to remote delivery of 
psychological therapies via telephone or video calls. While technologically able 
OAs may adjust well to this change, digital delivery of psychological therapies 
may not suit all OAs (BPS-FPOP, 2020a). Therefore, it could become an 
access to care barrier, especially as remote delivery methods may remain at the 
core of service delivery within psychological services for OAs for some time. 
This study was therefore re-designed with COVID-19 and concomitant changes 
to service delivery in mind.  
AIMS 
The primary aim was to establish the feasibility and acceptability of using 
self-report questionnaires to elicit OAs’ mental health treatment and outcome 
preferences and determine whether clinicians consider these preferences when 
selecting treatment. Hence, our focus is on understanding the response 
patterns from both people receiving services and the clinicians responsible for 
delivering psychological therapies. The secondary aim was to describe the 
mental health treatment and outcome preferences of OAs receiving 
psychological therapy during COVID-19 (including their preferences for remote 
delivery methods), and if clinicians account for patient preferences when 
selecting treatments.  
Research Questions 
Feasibility: 
1) What are the recruitment rates of eligible participants?  





b) What reasons are given for refusal/ineligibility? 
Acceptability: 
2) Is a self-report questionnaire, delivered remotely, an acceptable means of 
investigating OAs’ treatment and outcome preferences/whether clinicians 
account for patient preferences when selecting treatments? 
a. Are participants able to understand the questionnaire items? 
b. Does the questionnaire take a reasonable amount of time to 
complete?  
c. Do participants think the questionnaire items are relevant to them? 
Exploratory Analyses: 
3) What are OAs’ treatment and outcome preferences during COVID-19? 
4) Do clinicians account for patient preferences when selecting treatment? 




This study used a cross-sectional, quantitative design and aimed to 
describe the feasibility and acceptability of study procedures, in line with the 
Medical Research Council’s guidance on process evaluation of complex 
interventions (Moore et al., 2015). Because variations in uptake of 
psychological therapies will be a major factor in determining treatment 







Patients were recruited from those receiving psychological therapy for a 
mental health problem within NHS Lanarkshire’s Psychological Therapies for 
Older People (PTOP) and had the capacity to consent to research. PTOP 
typically accepts referrals of people aged 65 years or older, but younger 
patients presenting with issues related to ageing may also be seen and were 
thus eligible to participate. Patients whose command of English required an 
interpreter or who presented with significant current risk to themselves and/or 
others, were not eligible to participate.  
Clinician Participants 
Clinicians who deliver psychological therapy to OAs with mental health 
difficulties were recruited from OA psychology teams in three Scottish Health 
Boards: NHS Lanarkshire, NHS Greater Glasgow and Clyde and NHS 
Highlands. Therefore, this was a multi-site study.  
Justification of Sample Size 
Due to the feasibility focus of this study, and in line with NIHR (2019) 
guidance, no formal sample size calculations were completed. A target sample 
size of 30 patient participants, as previously recommended for feasibility studies 
(Browne, 1995), was thought sufficient to address the study questions. 
Similarly, the aim was to recruit as many eligible clinicians as possible, but a 






Patients were recruited by clinician referral. PTOP clinicians 
(independent of the research team) informed eligible patients on their caseload 
about the study. The contact details of patients who expressed interest in taking 
part were passed on to the researcher, who sent them the Participant 
Information Sheet (PIS; Appendix 2.3) and consent form (Appendix 2.4) by their 
preferred method (i.e. by email or in the post). The researcher then contacted 
interested patients by telephone to arrange a suitable appointment time to 
discuss the study further. During this appointment, which occurred remotely by 
telephone, the researcher went through the PIS and consent form, to check 
understanding; re-confirmed eligibility, to ensure accuracy; and answered the 
patients’ initial questions. Patients were advised that participation was 
voluntary, and they could withdraw at any time. They were given at least 24 
hours to decide if they wished to participate.  
It was originally planned that patients would complete the study 
procedures in a face-to-face appointment with the researcher, at an NHS site or 
in the participants’ home (as required). However, study procedures were 
updated following COVID-19 and the introduction of social-distancing 
measures. Therefore, participants were given the choice of completing the 
study procedures electronically or using paper copies sent in the post. 
Participants opting to receive paper copies were provided with a stamped 
envelope so they could return completed questionnaires for free. All participants 





Clinicians were invited to participate via an email circulated on 30th 
November 2020 by the Heads of Older People Psychology (HOOPs) in each 
participating health board. The email contained information about the study 
(PIS; see Appendix 2.5) and a link to the questionnaire, hosted on 
Surveymonkey.com. The PIS informed clinicians that their participation was 
voluntary and completely anonymous. All participants were asked to provide 
online consent (see Appendix 2.6). A participation reminder email was sent a 
month after the original email was circulated, using the same process. 
Data Collection 
Patient Sociodemographic data 
Sociodemographic data that has previously been associated with patient 
preferences was collected directly from patients as part of study procedures. 
This included age; sex; self-reported presenting problem and previous 
experience of psychological therapy.  
Clinician Demographics 
Previous research identified a number of clinician characteristics that 
influence whether they consider patient preferences when making clinical 
decisions, such as: their highest professional qualification, years of clinical 
experience, and main therapeutic modality (Gyani et al., 2014; Morrow-Bradley 
& Elliott, 1986; Safran et al., 2011; Stewart et al., 2018). This information was 





Two self-report questionnaires were adapted from previous research for 
this study. 
Patient Preferences Questionnaire (PPQ; Appendix 2.8) 
Patient participants were asked to complete the PPQ, a 51-item self-
report measure of patients’ preferences for various aspects of psychological 
therapy. The PPQ encompasses instructions and items from the Psychotherapy 
Preferences and Experiences Questionnaire (PEX; Clinton et al., 1999), a 
measure of preferences that has been found to have good internal consistency 
(Clinton & Sandell, 2014). However, the PEX has not been used with OAs. 
Therefore, the PPQ also incorporates items from a list of psychological therapy 
tasks and outcomes, developed as part of a previous preferences study with 
OAs in PTOP (Butrimaviciute, 2020). Butrimaviciute (2020) generated this list 
by identifying the key tasks involved in and expected outcomes of the 
psychological therapies recommended in the Older Adult Mental Health Matrix 
(NES, 2015), and the list was reviewed by PTOP clinicians (with experience of 
delivering psychological therapies to OAs). 
PPQ items are grouped into four sub-sections: therapy delivery format, 
therapist characteristics and approach, psychotherapy tasks, and 
psychotherapy outcomes. Each item is preceded by the phrase ‘I would prefer 
to…’ and participants are asked to rate how much they agree with this 
statement using a Likert scale that ranges from ‘Not at all’ (scored as 1) to 
‘Completely’ (scored as 6). The PPQ takes approximately 25 minutes to 
complete. Given that it was developed for this study and the 




use with OAs. Further details of its’ items and their origins can be found in 
Appendix 2.9. 
Clinician Decision-Making Questionnaire (CDMQ; Appendix 2.10) 
Clinician participants were asked to complete the CDMQ, a 26-item self-
report questionnaire that aims to measure different factors that affect their 
decision-making. It has three subsections: the first section was adapted from 
Morrow-Bradley and Elliot (1986) and asks clinicians to rate the extent to which 
different factors impact on their decision-making when selecting treatments; the 
second section asks clinicians to rate the extent to which different factors 
influence whether they consider client preferences when selecting treatments; 
and, the third section was added during the COVID-19 pandemic to explore 
whether the concomitant changes to service provision have influenced 
clinicians’ ability to accommodate patient preferences.  
Clinicians are asked to rate how influential each factor is on their 
decision-making using a six-point scale that ranges from ‘Not at all’ (scored as 
1) to ‘More than any other factor’ (scored as 6). This scale was used in Morrow-
Bradley & Elliot (1986). The CDMQ takes approximately 20 minutes to 
complete. See Appendix 2.11 for further details of its’ items and their origins.  
Acceptability of Measures 
Participants were asked three questions pertaining to the feasibility and 
acceptability of the measure they completed (i.e. PPQ or CDMQ). These 





All data were analysed using SPSS, version 27. Descriptive statistics 
were used to address each of the study questions in turn.  
Q1. The number of patients to progress through each stage of 
recruitment, along with their reasons for non-engagement/exclusion was 
recorded. Recruitment, response, and completion rates were calculated.  
Q2. Descriptive statistics of participant responses regarding the length, 
understandability and relevance of the questionnaires were calculated and 
presented. 
Q3, 4 and 5. Exploratory analyses were conducted with participants’ 
responses on the questionnaires to obtain initial indications of response 
distributions.  
Ethical Considerations 
West of Scotland Research Ethics Service gave favourable opinion for 
the study (Ref: 20/WS/0143). NHS Research and Development Management 
Approval was also obtained from each participating health board. Copies of 




Patient participants were recruited between 16th November and 31st 
December 2020. During this recruitment period, ninety-eight patients were 
receiving psychological therapy from fifteen PTOP clinicians and forty of these 




main reasons for not discussing the study with a patient were case complexity 
(i.e. multi-morbidity, severe or enduring mental health difficulties and/or 
significant distress) and/or suicidality. Twenty-eight patients (70%) agreed to be 
contacted by the researcher to discuss the study further. Three of the referred 
patients were not contactable by phone and voicemail messages could not be 
left, due to data protection. Of the twenty-five patients (63%) whose eligibility 
was reassessed, twenty-one (53%) verbally agreed to participate, but only 
eighteen (45%) provided written consent and returned their completed 
questionnaires (Figure 2). The sample attrition rate from verbal consent to study 
completion was 14.3% (i.e. study response rate was 85.7%).  
Patient demographic characteristics are summarised in Table 3 (data 
missing for two participants). Most participants were female, under the age of 
85 and had previous experience of psychological therapy. Approximately half of 

























Presenting Problem**  




Difficulties adjusting to a major life event 1(5.6) 
Complicated grief 3(16.7) 
Trouble sleeping 6(33.3) 
Difficulties coping with a physical health condition 7(38.9) 
Previous experience of psychological therapy  
Yes 10(55.6) 
No 6(33.3) 
*Values are n(%) 






Figure 2: Patient flow through recruitment stages 
 
Clinician Participants 
Clinician participants were recruited between 30th November and 31st 
December 2020. It was estimated that 45 clinicians were eligible for recruitment 
from participating health boards during this time. Twenty-seven of these (60%) 
 
Informed about the study (n=40) 
Questionnaire not returned; 
reason unknown (n=3) 
Eligible and verbally agreed to 
participate (n=21) 
Receiving psychological therapy 
(n=98) 
Agreed to be contacted about 
the study (n=28) 
Met remotely with researcher 
(n=25) 
Consented and completed 
questionnaire (n=18) 
Reasons for non-participation: 
• Too busy (n=2) 
• Not interested (n=1) 
• Feels too anxious (n=1) 
• Reason not stated (n=8) 
Unable to contact 
(n=3) 
Reasons for non-participation: 
• Too busy (n=1) 
• Feels too anxious (n=1) 
• Sensory difficulties (n=1) 




provided online consent and started the CDMQ, but one discontinued the 
questionnaire prior to completion. Clinicians had between 1- and 17-years 
clinical experience (M=8.2, SD=4.7), and were mostly Clinical Psychologists 
(n=20, 76.9%). The other clinicians stated their highest level of qualification was 
a master’s degree (n=5, 19.2%) or a Postgraduate diploma without a research 
component (n=1, 3.9%). Clinicians varied in terms of their main therapeutic 
modality: CBT was selected most frequently (n=11, 42.3%), followed by 
‘eclectic or integrative mix’ (n=10, 38.5%); Acceptance and Commitment 
Therapy (n=3, 11.5%) and Compassion Focused Therapy (n=2, 7.7%).  
Acceptability 
Acceptability of PPQ 
All respondents (n=18) rated the PPQ length as ‘About Right’ and its’ 
items as relevant (n=16, 88.9%) or ‘Sort of’ relevant (n=2, 11.1%) to their 
circumstances. In addition, respondents rated the PPQ as ‘Very Easy’ (n=6, 
33.3%), ‘Easy’ (n=7, 38.9%) or ‘Okay’ (n=5, 27.8%) to understand. Overall, 
patient participants seemed to find the PPQ acceptable. 
Acceptability of CDMQ 
Most clinicians rated the CDMQ length as ‘About Right’ (n=24, 88.9%), 
but two thought it was ‘Too Short’ (7.4%). Its’ items were rated as relevant 
(n=23, 85.2%) or ‘Sort of’ relevant (n=3, 11.1%), and ‘Very Easy’ (n=18, 66.7%), 
‘Easy’ (n=6, 22.2%) or ‘Okay’ (n=2, 7.4%) to understand. Therefore, 
acceptability of the CDMQ appeared to be good, despite data missing data for 





Response distributions for the PPQ’s four sub-sections are explored 
below (frequency data for each item is available upon request).  
Treatment preferences 
Psychotherapy Delivery Format (see Table 4):  
Patients’ most preferred therapy format, on average, was individual face-
to-face therapy in a clinic, followed by individual therapy over telephone and 
individual face-to-face therapy at home. Patient ratings for other delivery 
formats, including individual therapy over video call, were relatively low and 
group therapy over video call was the least preferred. However, participants 
seemed to vary in their preferences, which was illustrated by the dispersion of 
ratings (i.e. range) for each therapy format. Item completion rates for this 
subsection ranged from 78 to 94%. 
Table 4: Preferences for therapy delivery format 
 N Mean(SD) Mode Range 
Individual therapy over telephone 15 3.9(1.8) 6 5 
Individual therapy over video call 14 2.6(2.1) 1 5 
Individual, face-to-face therapy in clinic 17 4.1(1.9) 6 5 
Individual, face-to-face therapy at home 15 3.4(2.2) 1 5 
Group therapy over video call 16 1.6(1.1) 1 4 
Self-help workbooks with remote therapist 
support 
16 2.5(1.7) 1 5 
Unguided Computerised-CBT 16 2.0(1.3) 1 4 
 
Therapist Characteristics and approach (see Table 5):  
On average, more participants preferred a female therapist to a male. In 
terms of therapist approach, the strongest preferences (in either direction) were 
‘a therapist who listens and tries to understand’ (preferred) and ‘a therapist who 




these two items was low, demonstrating most participants held a strong 
preference for them. Item completion rates for this subsection ranged from 89 to 
94%. 
Table 5: Preferences for therapist characteristics and approach 
 N Mean(SD) Mode Range 
Male Therapist 16 3.7(2.3) 6 5 
Female Therapist 17 4.9(1.8) 6 5 
A therapist who gives advice 17 5.0(1.1) 6 4 
A therapist who provides practical support 17 4.8(1.7) 6 5 
A therapist who is non-judgmental 16 5.4(0.9) 6 2 
A therapist who tells me what to do 17 3.2(1.9) 1 5 
A therapist who validates my experiences 17 4.8(1.5) 6 5 
A therapist who listens and tries to understand 17 5.7(0.6) 6 2 
 
Therapy Tasks (see table 6):  
Based on mode values, participants considered most of these tasks 
important (‘6’ = ‘Completely’ prefer). ‘Learn ways to be less critical of me’ was 
the most preferred task and the task with the strongest preference. ‘Reflect on 
painful memories’ was the least preferred task in terms of mean value, but the 
mode demonstrates many participants preferred this ‘Completely’. Item 












Table 6: Preferences for therapy tasks 
 N Mean(SD) Mode Range 
Notice and change unhelpful thoughts 17 5.2(1.4) 6 5 
Notice and change unhelpful patterns of 
behaviour 
17 5.2(1.5) 6 5 
Learn to face situations I fear (reduce 
avoidance) 
17 5.1(1.2) 6 4 
Reflect on painful memories 16 4.2(1.8) 6 5 
Learn ways to become more active 17 4.5(1.5) 5* 5 
Learn strategies and skills to deal with 
problematic situations 
17 5.2(0.9) 6 2 
Learn to take my thoughts less seriously and be 
less caught up in them 
17 5.1(1.2) 6 4 
Learn to be ok with unwanted emotions, even if 
I can’t get rid of them completely 
17 4.9(1.3) 6 4 
Learn meditation techniques 17 4.8(1.6) 6 5 
Clarify my values 17 5.1(1.0) 6 3 
Build kindness and self-compassion 17 5.0(1.0) 5 4 
Learn ways to be less critical of me 18 5.3(0.8) 6 2 
Explore links between earlier life and how this 
affects my life presently 
18 4.7(1.5) 6 5 
Learn skills for improving my relationships 18 4.4(1.6) 6 5 
Develop skills to overcome loneliness 18 4.3(1.7) 5* 5 
Talk over the course of my life 18 4.7(1.6) 6 5 
Explore the loss of a loved one 17 4.4(1.7) 6 5 
Talk about major life changes to help me adjust 
to them 
18 4.5(1.6) 5* 5 
*Multiple modes exist. The smallest value is shown. 
 
 
Outcome preferences (Table 7) 
Again, based on mode values, participants considered most of these 
outcomes important (‘6’ = ‘Completely’ prefer). According to means, the most 
preferred outcome was ‘feel more confident’ and the least preferred was ‘feel 
less lonely’. However, a wide range of responses were selected for the latter. 





Table 7: Outcome Preferences 
 N Mean(SD) Mode Range 
Have a sense of purpose and meaning in my 
life 
16 5.3(1.1)  6 3 
Feel more hopeful* 17 5.5(0.9) 6 3 
Like myself 17 5.4(0.9) 6 3 
Have more energy to do things 17 5.4(0.7) 6 2 
Have improved relationships with others 17 4.9(1.2) 6 4 
Feel less lonely* 17 4.3(1.8) 6 6 
Have learned how to focus less on/worry less 
about my physical health 
17 5.1(1.4) 6 6 
Feel more able to cope with uncertainty* 17 5.0(1.2) 6 3 
Sleep better 16 5.0(1.6) 6 5 
Have more things to do in my week 17 4.6(1.3) 4 5 
Feel less troubled by past memories 18 5.4(0.9) 6 3 
Have learned to live with pain and other 
physical difficulties 
17 5.1(1.4) 6 6 
Feel more confident 17 5.6(0.6) 6 2 
Be less bothered by worries 18 5.4(0.8) 6 2 
Have learned how to manage my nerves and 
uncomfortable feelings in my body 
18 5.1(1.4) 6 5 
Have made sense of my life 17 5.1(1.1) 6 4 
Have come to terms with the loss of somebody 17 4.8(1.1) 6 5 
Have adjusted to major life changes  17 4.5(1.7) 6 5 
*added in response to COVID-19 and the predicted impact of self-isolation 
 
Clinician decision-making 
Frequency data for clinicians’ responses is available upon request.  
Factors that influence clinicians’ decision-making when selecting treatments 
(see Table 8) 
This section of the CDMQ asked clinicians to rate the relative impact of 
various factors on their decision-making when selecting treatments. The mean 
ratings suggest that the factors with the most influence on clinicians’ decision-
making were their own experience with clients, best practice guidance and 




own experience of being a client. In terms of patient preferences, clinicians 
were most influenced by patients’ preferences for format of therapy, but 
preferences for therapy tasks and outcomes were considered ‘moderately’ 
influential, on average. Completion rate for this section of the CDMQ was 100%.  
Table 8: Factors that influence clinicians' decision-making 
 N Mean(SD) Mode Range 
Best Practice Guidance 27 4.6(0.8) 5 4 
Quantitative Research  27 3.8(0.8) 4 3 
Qualitative Research  27 3.0(0.9) 3 4 
Information from CPD events 27 3.7(0.9) 3 3 
Your own clinical experience with clients 27 4.7(0.7) 5 3 
Your own experience of being a client 27 1.9(1.0) 1 3 
Supervision/ consultation with others 27 4.6(0.8) 5 3 
Client preferences for tasks of therapy 27 4.3(1.1) 4 4 
Client preferences for format of therapy 27 4.4(1.2) 5 4 
Client outcome preferences 27 4.3(0.9) 4 3 
Factors that affect whether clinicians’ take account of preferences (see Table 9)  
Most factors had a mode value of ‘5’, which means they were most 
frequently rated as having ‘a great deal’ of influence on whether clinicians 
consider patient preferences. The one exception to this was clinicians’ ‘own 
preference for treatment modality’, which was rated to have the least influence 
on this decision. According to means, the factors with the most influence on 
whether clinicians consider patient preferences were client insight and previous 
experience of mental health support. The completion rate for this section of the 
CDMQ was 96%. 
COVID-19 Questions 
All respondents stated they had to make changes to the way they 
delivered psychological therapies in response to COVID-19 and related public 




remote methods of delivery), would continue with OAs following the relaxation 
of infection control measures. All but one respondent (92.6%) believed these 
changes had made it more difficult for them to accommodate patients’ treatment 
preferences, including their preferences for delivery format and/or tasks of 
therapy.  
Table 9: Factors that affect whether clinicians consider preferences 
 N Mean(SD) Mode Range 
Type of Presenting Problem (PP) 26 4.2(1.1) 5 4 
Severity of PP  26 4.3(0.8) 5 2 
Case complexity 26 4.3(0.9) 5 3 
Presence of co-morbidities 26 3.9(1.0) 5 3 
Client insight into their difficulties 26 4.4(0.8) 5 2 
Client’s previous experience of mental health 
support 
26 4.4(0.8) 5 3 
Strength of client preferences 26 4.2(0.8) 5 2 
Own preferences for treatment modality 26 3.4(0.9) 3 4 
 
DISCUSSION 
This study aimed to establish the feasibility and acceptability of using 
self-report questionnaires to elicit OAs’ mental health treatment and outcome 
preferences and determine whether clinicians consider these preferences when 
selecting treatment. It also aimed to describe preliminary data from participants’ 
responses to the questionnaires.  
Feasibility and Acceptability  
Patient Participants 
Eighteen patients were recruited into the study. The majority of OAs 
receiving psychological therapy within PTOP during the recruitment period were 




certain patients based on their clinical complexity and/or concerns about risk. 
The latter is likely due to the study’s exclusion criteria, but patients with complex 
difficulties who do not present with risk could have been referred. Some 
clinicians raised concerns about the PPQ length and questioned its 
appropriateness for OAs due to issues with response burden (i.e. the effort 
required to answer a questionnaire). Evidence supporting the association 
between questionnaire length and response burden is limited (Rolstad et al., 
2011), and the PPQ length was justified by the feasibility/acceptability focus of 
this study. It is possible that individual clinicians’ attitudes about research in 
general, the study procedures and what is appropriate for OAs may have 
influenced who they informed about the study and led to unequal opportunities 
to participate across the service.  
Other barriers to recruitment were inconvenience (e.g. busy time of 
year), difficulties contacting patients by phone and physical illness. Patients’ 
reasons for non-engagement and dropout were not always stated and could 
indicate issues with study feasibility. Furthermore, one interested patient was 
unable to participate independently due to them being registered blind and 
living alone, and the researcher did not have ethical approval to assist their 
completion of the questionnaire. Due to OAs commonly presenting with sensory 
difficulties (Scottish Government, 2014), this issue requires careful 
consideration in future research to ensure equal opportunity to participate. 
To our knowledge this is the first study to use a self-report questionnaire 
to measure treatment and outcome preferences for psychological therapies with 
OAs. Overall acceptance of the PPQ was good and ratings of relevance and 




about the length of the PPQ, all patients rated it to be ‘about right’. However, 
item completion rates varied across the PPQ (range: 78-100%) and represented 
missing data from seven participants. Reasons for missing data are unknown 
but could indicate an issue with questionnaire acceptance. For instance, 
participants possibly skipped items that did not apply to them rather than stating 
a low preference. This could suggest that PPQ instructions need to be 
amended for clarity, though item completion is generally a recognised problem 
in research that uses posted questionnaires with OAs (Palonen et al., 2016).  
Clinician Participants 
Twenty-seven clinicians were recruited across the four week recruitment 
period, which is slightly below the target sample. We hoped to recruit as many 
clinicians as possible from across all Scottish Health Boards, but HOOPs in only 
three health boards had agreed to circulate the CDMQ before ethics 
submission. This significantly reduced the number of clinicians available for 
recruitment. In terms of study acceptability, most clinicians rated the CDMQ 
length as ‘about right’ and they generally felt the items were relevant to them 
and easy to understand. One clinician discontinued the CDMQ prior to 
completion, but the forced-choice format of the online questionnaire meant that 
data was otherwise complete. Overall, data suggests that acceptability of the 
CDMQ was good. 
Patient Preferences 
There are several limitations that should be considered when interpreting 
these preliminary findings, including the potential impact of outliers due to the 
small sample size and social desirability bias due to the self-report nature of the 




heterogeneity in patient preferences, which is a known difficulty when 
attempting to generalise preferences findings (Meara et al., 2019). However, 
some patterns in the data warrant closer analysis and discussion, provided 
below.   
In terms of psychotherapy delivery format, patients showed a strong 
preference for in-person or telephone therapy over remote, digital options, 
which included computerised CBT and video-call delivered therapy. This poses 
a challenge to the Scottish Government’s (2020) COVID-19 Mental Health 
Transition and Recovery Plan to OAs. This plan recognises that OAs may not 
have access to digital technologies, but it does not describe how services 
should meet OAs’ mental health needs without the use of digital therapy. 
Beyond policy implications, services may be restricted in their ability to offer in-
person therapy during and after COVID-19. This limits their ability to 
accommodate this preference, which could have implications for therapy 
adherence, engagement and outcome, in line with previously reported findings 
(Swift et al., 2018). The present study did not record whether participants had 
experience of psychological therapy delivered remotely. This would be a useful 
line of subsequent enquiry given previous research found that experience 
influences preferences (Corrigan & Salzer, 2003). Increased understanding of ‘if 
and why’ preferences change with experience of remote therapy could be used 
to determine how best to present this option to OAs who are ambivalent about 
engaging remotely.  
Patients expressed a preference for a therapist of a particular sex, with 
most preferring female therapists. This comports with previous studies (Pikus & 




preference for both sexes simultaneously in this study. This highlights the 
limitations of using a questionnaire to elicit preferences, as it does not mimic the 
trade-offs inherent in real life decision-making.  
On average, patients showed positive preferences for most tasks, which 
demonstrates the clinical utility of the therapy modalities represented in the 
PPQ, with OAs. For instance, the most preferred task was ‘learning ways to 
reduce self-criticism’, which could be met through the provision of psychological 
therapies that specifically incorporate this task. However, this was one of two 
PPQ items that relates to Compassion Focused Therapy (CFT; Gilbert, 2010), 
the efficacy of which is yet to be established with OAs. Therefore, this illustrates 
a gap between clinical need and research, which would benefit from 
exploration.   
There was little variance in the mean values for outcome preferences, 
suggesting they were all desired by participants to some extent. Three 
outcomes were added to the PPQ in response to COVID-19, and the predicted 
impact of self-isolation on OAs’ mental health. These items included: ‘feel more 
hopeful’, which was the second most preferred outcome on average; and ‘feel 
less lonely’, which was the least preferred outcome on average. These 
preferences could be guided by participants’ presenting problems. For instance, 
the majority of the sample self-identified anxiety as one of their reasons for 
seeking treatment, which is often associated with worries about worst case 
scenarios. Therefore, psychological therapy that targets anxiety may result in 
them feeling more hopeful. Fewer participants identified depression as one of 
their reasons for seeking treatment, which could explain why feeling less lonely 





EBP has three components: ESTs, clinician expertise and patient 
characteristics/preferences (Sackett et al., 2000). Clinicians identified their own 
clinical experience as the component that has the most influence on their 
decision-making when selecting treatments, followed by published best practice 
guidance. These finding are consistent with previous research that found 
clinicians favour their own clinical experience over research evidence when 
making treatment decisions (Gyani et al., 2014; Safran et al., 2011; Stewart et 
al., 2018). However, clinicians in this study rated patient preferences to have 
‘quite a lot’ of influence on their decision-making about treatments, which 
contrasts to prior research finding the opposite (e.g. Stewart et al., 2018). It is 
possible that the self-report nature of the CDMQ may have introduced social 
desirability bias to these results. 
Factors that influence whether clinicians considered patient preferences 
were also investigated with the CDMQ and the most influential factors were 
client insight and previous experience of mental health support. However, due 
to the way this question is worded (i.e. ‘How much does this factor influence 
whether I consider client preferences when selecting appropriate treatments?‘), 
it is unclear if clinicians are more or less likely to accommodate patient 
preferences based on these factors. This relationship could be explored in 
future research.  
Additional items were added to the CDMQ to explore the impact of 
COVID-19 on psychological services for OAs. Most clinicians believed that 
changes in service provision such as remote and/or digital delivery of therapy 




more difficult for them to accommodate patient preferences for delivery format. 
This further illustrates the mismatch between what services can offer during and 
after COVID-19 and the preferences of OAs seeking treatment.   
Strengths and Limitations 
This study demonstrates the feasibility of recruiting OAs and clinicians to 
research during the COVID-19 pandemic. However, as with all small n, 
feasibility studies, caution is required when interpreting the preliminary findings 
due to the potential impact of outliers and heterogeneity of responses. 
Additionally, the exclusion of patients with greater clinical risk and/or complexity 
potentially introduced selection bias, raising issues with sample 
representativeness. It is possible that the excluded patients represent a ‘harder 
to reach’ group and thus understanding their treatment and outcome 
preferences would support services to offer them acceptable interventions. Data 
on participant race/ethnicity was also not collected, further limiting the 
interpretation and generalisability of results.  
The fact that clinicians identified eligible patients from their caseload is 
another limitation of this study. In addition to being a barrier to recruiting certain 
clients, it could have introduced power imbalance issues in therapeutic 
relationships. For instance, although patients were assured that non-
participation would not affect their current or future NHS care, they may have 
felt obligated to participate. Timing of recruitment is another limitation, in that all 
participants were engaged in psychological therapy when approached about 
participating. The study could have highlighted discrepancies between patients’ 
preferences and what they were receiving, but the impact of this on their 




The questionnaires themselves also have limitations. Firstly, the PPQ did 
not consider patient preferences for therapists of a particular race/ethnicity, and 
other protected characteristics, as services are unlikely to accommodate such 
preferences for ethical reasons (i.e. to prevent discrimination). However, it could 
have been valuable to explore the existence of these preferences, as certain 
patients may have valid, therapeutic reasons for needing them accommodated. 
Secondly, we aimed to identify an efficient means of eliciting patient 
preferences, and the development and trialling of the PPQ was a good starting 
point, but formal feedback from participants about questionnaire format and 
language was not elicited. Therefore, we do not know how patient participants 
felt about the language used in the questionnaire (e.g. do they prefer ‘talking 
therapy’ to ‘psychotherapy’?). It will be important to elicit such feedback as the 
questionnaire continues to be refined. Lastly, as items in the PPQ were largely 
based on Matrix recommended psychological therapies for OAs (NES, 2015), 
content is lacking on underrepresented presenting problems, such as 
psychosis. This is a significant limitation of the PPQ, as it does not encompass 
items relevant to all difficulties experienced by treatment-seeking OAs, and 
further highlights the gap between ESTs available for use with OAs and clinical 
need.   
Implications and Future Research 
 The preliminary findings from PPQ data highlight the limitations 
associated with clinicians only basing their treatment decisions on ‘the best 
available research evidence’, which is usually interpreted as the findings of 
randomised controlled trials (RCTs). While these findings may evidence the 




symptoms, they fail to account for patient preferences. The current study 
suggests that patients’ preferred outcomes (e.g. ‘to feel more confident’) differ 
to those assessed and reported in RCTs, and those routinely monitored in 
clinical practice. This finding comports with existing research into Patient 
Reported Outcome Measures (PROMs; e.g. Kingsley & Patel, 2017), which 
recognises the limitations of symptom improvement outcomes and the 
importance of understanding what matters to patients for improving service 
quality. Consequently, mental health funders are increasingly moving towards 
exploring and achieving patient identified outcomes (Hooper et al., 2020) and, 
once refined, the PPQ could support this by identifying outcomes of importance 
for OAs and informing appropriate selection of PROMs.   
To refine the PPQ, future research should address the research 
questions with a larger, more representative sample, across a longer 
recruitment period. This research needs to consider means of improving patient 
referral rates, data completion for the PPQ and access to OAs with sensory 
impairments. The present study suggests that clinicians may have reservations 
about discussing research opportunities with clients with complex difficulties, 
regardless of their supposed eligibility. To address this recruitment barrier, 
future research will either need to increase clinician buy-in and understanding of 
the study rationale, or recruit via other methods (e.g. identify eligible patients 
through referral databases). To maximise data completion, Palonen et al. 
(2016) recommended collecting data in the presence of the researcher, as was 
the intended plan for this study prior to COVID-19. However, face-to-face 
appointments for research may not be feasible during and after COVID-19, and 




ability to attend appointments; Woodall et al., 2010). Instead, patients could 
complete the questionnaires in a remote appointment with the researcher held 
over telephone or video call (based on preference). Patient feedback on the 
format and language used in the PPQ should also be elicited.  
Such research could address issues with measure standardisation and 
may reveal patterns in the data that were not observable due to the small 
sample in this study. This data could assist clinicians and researchers to better 
understand OAs treatment and outcome preferences and adapt services 
accordingly.  
Conclusion 
This study aimed to assess the feasibility and acceptability of using self-
report questionnaires to elicit OAs treatment and outcome preferences and 
factors that influence clinicians’ decision-making when selecting treatment. A 
reasonable number of patient and clinician participants were recruited despite 
challenges related to the COVID-19 pandemic. Acceptability of the 
questionnaires was good, but replication of the patient arm of this study with a 
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Appendix 1.2 Annotated search strategy 
A line-by-line search strategy was used for all databases. The example 
below shows how terms for the three groups were applied to EBSCOhost 
CINAHL (1937-present), when searched on 23/01/2021.   
Table 10: Annotated search strategy 
# Searches 
S1  (MH "Aged+") 
[S1 is a subject heading for the population i.e. group 1: OAs] 
S2  TI older adult* OR AB older adult* 
S3  TI older people OR AB older people 
S4  TI older person* OR AB older person* 
S5  TI older patient* OR AB older patient* 
S6  TI elderly OR AB elderly 
[S2-6 are textwords for OAs] 
S7  S1 OR S2 OR S3 OR S4 OR S5 OR S6 
[S7 is the OAs group] 
S8  (MH "Psychotherapy+") 
[S8 is a subject heading for the intervention i.e. group 2: psychological 
therapies] 
S9  TI cognitive behavio#ral therap* OR AB cognitive behavio#ral therap* 
S10  TI psychodynamic psychotherap* OR AB psychodynamic psychotherap* 
S11  TI psychological therap* OR AB psychological therap* 
S12  TI psychological intervention* OR AB psychological intervention* 
S13  TI CBT OR AB CBT 
S14  TI cognitive therap* OR AB cognitive therap* 
S15  TI behavio#ral therap* OR AB behavio#ral therap* 
S16  TI acceptance n2 commitment therap* OR AB acceptance n2 
commitment therap* 
S17  TI dialectical behavio#ral therap* OR AB dialectical behavio#ral therap* 
S18  TI compassion focused therap* OR AB compassion focused therap* 
S19  TI interpersonal therap* OR AB interpersonal therap* 
S20  TI mindfulness-based cognitive therap* OR AB mindfulness-based 
cognitive therap* 
S21  TI schema therap* OR AB schema therap* 
S22  TI problem-solving therap* OR AB problem-solving therap* 
[S8-22 are textwords for psychological therapies] 
S23  S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 
OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 





S24  (MH "Telemedicine+") 
S25  MH "Videoconferencing") 
S26  (MH "Telephone+") 
S27  (MH "Telepsychiatry") 
[S24-27 are subject headings for intervention format i.e. group 3: remote 
delivery] 
S28  TI video conferenc* OR AB video conferenc* 
S29  TI Telehealth OR AB Telehealth 
S30  TI tele-mental health OR AB tele-mental health 
S31  TI telemental health OR AB telemental health 
S32  TI telepsychiatry OR AB telepsychiatry 
S33  TI telepsychology OR AB telepsychology 
S34  TI telepsychotherapy OR AB telepsychotherapy 
S35  TI telecounseling OR AB telecounseling 
S36  TI video call* OR AB video call* 
[S28-S36 are textwords for remote delivery] 
S37  S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR 
S32 OR S33 OR S34 OR S35 OR S36 
[S37 is the remote delivery group] 
S38  S7 AND S23 AND S37 





















(Max 100) Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16 
Brenes et al. (2012) 0 5 0 0 0 0 6 10 0 0 0 0 0 3 0 0 24 
Brenes et al. (2015) 0 5 10 3 0 10 6 10 0 0 10 5 10 3 3 5 80 
Brenes et al. (2016) 0 5 0 0 0 0 6 0 0 0 10 5 0 0 3 5 34 
Brenes et al. (2017) 0 5 10 3 0 10 6 10 0 0 10 5 0 0 3 5 67 
Brenes et al. (2020) 0 5 10 3 0 0 6 0 0 0 0 5 0 3 3 5 40 
Wilz and Soellner 
(2016) 
0 5 0 3 3 10 3 10 3 0 10 5 0 3 3 5 63 
Wilz et al. (2018) 0 5 10 3 0 10 3 0 0 0 6 5 0 3 3 5 53 
Barrera et al. (2017) 2 0 0 0 0 10 6 0 0 0 0 5 0 3 3 0 29 
Doyle et al. (2017) 2 5 10 3 3 10 6 10 0 0 10 0 10 3 3 5 80 
Wuthrich and Rapee 
(2019) 
0 0 10 3 0 0 6 0 0 0 0 0 0 3 3 0 25 
Dobkin et al. (2020) 0 5 0 3 0 10 6 10 0 0 6 5 0 3 3 0 51 
Lazzari et al. (2011) 0 0 0 0 0 0 6 0 0 0 0 0 0 3 3 0 12 
Lichstein et al. 
(2013) 
2 0 0 0 0 0 3 0 0 0 0 0 0 3 3 5 16 
Choi et al. (2014a) 2 5 0 0 0 0 6 0 0 0 10 5 10 0 0 5 43 
Choi et al. (2014b) 2 5 10 3 0 0 6 0 0 0 10 5 10 3 3 5 62 
Choi et al. (2016) 2 5 10 0 0 10 6 0 0 0 10 0 10 3 0 0 56 
Choi et al. (2020) 2 5 10 3 3 0 6 0 0 0 10 5 10 3 3 0 60 
Egede et al. (2015) 0 5 10 3 3 10 6 10 0 0 10 5 10 3 3 5 83 
Egede et al. (2016) 0 5 10 3 3 10 6 10 0 0 10 0 10 3 3 5 78 
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Background: Evidence-based practice requires using the best available 
research evidence, in conjunction with clinical expertise and patient 
characteristics/preferences, to inform the provision of appropriate interventions. 
Although patient treatment preferences have a significant positive impact on 
psychotherapy attendance and outcome, they are often overlooked in clinical 
decision-making. 
Aims: To establish the feasibility and acceptability of using self-report 
questionnaires to elicit older adults’ (OA) mental health treatment and outcome 
preferences and determine whether clinicians consider these preferences when 
selecting treatment. The secondary aim is to establish a preliminary 
understanding of OA’ mental health treatment and outcome preferences, and 
how clinicians account for patient preferences when selecting treatments.  
Methods: Patients (over 65) and clinicians will be recruited from NHS 
Lanarkshire and asked to complete questionnaires (feasibility and acceptability 
testing) and gain preliminary descriptive data from responses to the 
questionnaires.  
Applications: Findings will improve methods for understanding treatment and 
outcome preferences in OAs. This will help clinicians in services better 
understand what OAs prioritise when seeking treatment and what they think 








Scotland has an ageing population; with a 50% increase in over 60s projected 
by 2033 (Scottish Government, 2010). People in this age range often present 
with multiple psychological and physical comorbidities (NHS Education 
Scotland [NES], 2015). Consequently, improving the provision of and access to 
health and social care services, including mental health services, for older 
adults (OA; age 65+) is a priority for the (Scottish Government, 2017, 2019). 
There are several barriers to achieving this priority, including increasing public 
expectations and financial constraints, but the Scottish Government hopes to 
overcome these by promoting the provision of ‘realistic medicine’ and ‘person-
centred care’ (Scottish Government, 2018). These approaches seek to change 
how services are delivered by introducing shared decision-making, aimed at 
determining what matters most to individual patients and developing a 
personalised approach to their care. These strategies also uphold the ethical 
principles of peoples’ right to self-determination and autonomy (e.g. British 
Psychological Society [BPS], 2018). Therefore, mental health services across 
Scotland need to adapt to this growing demographic and work jointly with 
patients to offer acceptable and beneficial interventions, including psychological 
therapies.  




Working within NHS Scotland mandates the delivery of EBP for the treatment of 
mental health difficulties (Gyani et al., 2014), which remains at the core of best 
practice. To date, most research into the efficacy of psychological therapies for 
OA has focused on Cognitive Behavioural Therapy (CBT) for depression or 
anxiety, which has been found to be as efficacious as other treatments and 
more effective than waiting list controls (Cuijpers et al., 2009; Hofmann et al., 
2012). There is also emerging evidence supporting the use of other 
psychological therapies with OA, including Acceptance and Commitment 
Therapy (ACT; Luci et al., 2016; Wetherell et al., 2011), expanding the number 
of empirically supported therapies (ESTs) available to them. However, the 
recent emphasis on developing ESTs, and providing interventions in line with 
the guidance outlined in ‘The Matrix’ (NES, 2015), has resulted in a reductionist 
view of EBP, largely neglecting its two other critical components: clinical 
expertise and patient characteristics (Sackett et al., 2000). This may explain the 
observed gap between research and practice (TenHave et al., 2003). 
A small, but significant literature has accumulated indicating that clinicians 
discount research evidence in favour of using their clinical experience to inform 
treatment decisions (e.g. Gyani et al., 2014; Safran et al., 2011; Stewart et al., 
2018). Clinicians may have valid reasons for their reluctance to implement 
ESTs, such as small, unrepresentative samples in psychological treatment 
outcome studies  (Corrigan & Salzer, 2003) and insufficient evidence to inform 
all treatment decisions (Stewart et al., 2018). However, there are well-
documented flaws associated with clinicians relying solely on their experience 




clinicians have been found to have differing views concerning the tasks and 
goals of treatment (Moritz et al., 2017), but a recent review of the factors that 
influence decision-making found that none of the surveyed clinicians based 
their treatment decisions on patient preferences (Stewart et al., 2018). 
Therefore, clinicians’ current approach to decision-making disregards patients’ 
expertise (Mühlbacher & Juhnke, 2013) and the emerging research that 
highlights the importance of patient preferences.  
Patient Preferences 
Patient preferences can be defined as “the behaviours or attributes of the 
therapist or therapy that a client values or desires” (Swift et al., 2011, p. 151), 
and divided into three categories: therapy tasks, therapy format and therapist 
characteristics (Swift et al., 2018). Treatment preferences are thought to arise 
from previous experience, which influences patients’ appraisal of treatment 
options and subsequently their motivation to change and degree of 
engagement (Corrigan & Salzer, 2003). In their recent meta-analysis, Swift et 
al. (2018) examined the effects of accommodating client treatment preferences 
on psychotherapy dropout and outcome and found a small but significant effect 
in favour of clients who received their preferred treatment. These results were 
in line with previous research (e.g. Swift et al., 2011), but some contradictory 
findings do exist (e.g. Leykin et al., 2007 - found no significant impact of 
matching patients to their preferred treatment on outcome or dropout). Despite 
this variability in results, preferences are likely to have an indirect effect on 
outcome through factors such as engagement, adherence and satisfaction 




To summarise, there is disproportionate attention given to ESTs in research 
and clinician experience in decision-making, at the expense of patient 
preferences (Stewart et al., 2018), despite findings suggesting they play a 
significant role in therapy attendance and outcomes (Swift et al., 2018). 
Additional research is required to determine if these findings are replicable with 
different patient groups. To date, little attention has been given to patients’ 
preferred treatment outcomes (i.e. what they hope to gain from therapy; Eiring 
et al., 2015). Furthermore, studies have described the relative pros and cons of 
a variety of methods that have been used to elicit patient preferences, but no 
preferred method has been identified (Ryan et al., 2001; Swift et al., 2018). In 
their systematic review of techniques used to elicit public preferences for 
healthcare, Ryan et al. (2001) recommended that research be carried out to 
test the available methods. Therefore, we will test preference identification 
methods with OAs and examine how clinicians take account of these 
preferences when planning treatment.  
AIMS 
To establish the feasibility and acceptability of using self-report questionnaires 
to elicit OA’ mental health treatment and outcome preferences and determine 
whether clinicians consider these preferences when selecting treatment. The 
secondary aim is to describe OA’ mental health treatment and outcome 







1. What are the recruitment rates of eligible participants?  
a. What proportion of participants are lost at each stage in the recruitment 
process? 
b. What reasons are given for refusal/ineligibility? 
Acceptability: 
2. Is a self-report questionnaire an acceptable means of investigating OA’ 
treatment and outcome preferences/whether clinicians account for patient 
preferences when selecting treatments? 
a. Are participants able to understand the questionnaire items? 
b. Does the questionnaire take a reasonable amount of time to complete 
or does it create a burden for the participants?  
c. Do participants think the questionnaire items are relevant to them? 
Exploratory Analyses: 
3. What are OA’ treatment and outcome preferences? 
4. Do clinicians account for patient preferences when selecting treatment? 
5. What factors influence clinicians’ use of patient preferences when selecting 
treatments? 
PLAN OF INVESTIGATION 
 Participants  
Two groups of participants will be recruited from NHS Lanarkshire (NHSL): 





Patient participants will be recruited from patients referred directly to 
community-held psychological therapy groups or to the Psychological 
Therapies for Older People service (PTOP) for individual psychological therapy. 
 
Recruitment Procedures:  
All patients whose referral to a group is screened as appropriate (i.e. meets the 
group referral criteria) attend a pre-group assessment with a group facilitator. 
Similarly, patients referred for individual therapy undergo an initial assessment 
with a clinician. Patients will either be informed of the study by their group 
facilitator/treating clinician (who are not part of the research team) at the end of 
their initial assessment (if they are deemed appropriate for group/individual 
psychotherapy) or in their final psychotherapy session. Patients who are 
interested in taking part will be provided with the participant information sheet 
(PIS) and consent form, and asked whether the Researcher can contact them 
to discuss the study. The Researcher will then contact consenting patients to 
discuss the study in more detail; answer their initial questions; ask if they wish 
to participate and check if they meet the eligibility criteria. If so, an appointment 
will be arranged to obtain written consent and carry out study procedures.  
Clinician Participants 
PTOP staff will be contacted via email to provide them with information about 




Within the email, they will be informed that the questionnaire is anonymous and 
provided with a secure link to the questionnaire website. After a month, they will 
be emailed a participation reminder. All participants will be asked to provide 
online consent and advised they are free to withdraw from the study at any 
point. If this process does not yield sufficient respondents, there is the 
possibility of circulating the questionnaire via the British Psychological Society’s 
‘Faculty of the Psychology for Older People’, with the aim of recruiting clinicians 
from OA psychology teams across the UK. 
Inclusion and Exclusion Criteria  
Patient Inclusion Criteria: 
• Capacity to consent to research 
• Age 65+ 
• Living in the community 
• Mental health difficulty that meets NHSL PTOP referral criteria for 
group/individual psychological therapy. 
Patient Exclusion Criteria: 
• Insufficient English language skills to allow meaningful participation. 
• Diagnosis of learning disability or cognitive impairment; mental state 
disturbance (e.g. acute psychosis) or substance abuse, if it prevents 
meaningful participation in psychological therapy.  
• Present with risk to self or others during psychological therapy or contact 
with researcher. 




• Working face-to-face therapeutically with people age 65+ with mental health 
difficulties. Will include Clinical Psychologists, Psychological Therapists and 
CBT Therapists.  
Design 
This feasibility study is descriptive and exploratory in nature. It uses a cross-
sectional, quantitative design and aims to describe the feasibility and 
acceptability of study procedures, in line with MRC guidance on developing and 




Two self-report questionnaires were developed for this study, but adapted from 
previous research:  
• The ‘Patient Preferences Questionnaire’ (PPQ; Appendix A) is a 48-item 
measure of patients’ preferences for various tasks and goals of therapy and 
characteristics known to affect the TR. The PPQ is flexibly constructed so 
that it can be used at two distinct points in time (i.e. before and after 
treatment). Further details of its’ items and their origins can be found in 
Appendix B. The PPQ will be reviewed by PTOP staff (with experience and 
expertise of the OA population presenting to mental health services) prior to 




• The ‘Clinician Decision-Making Questionnaire’ (CDMQ; Appendix C) has 26-
items and aims to identify to what extent clinicians account for patient 
preferences when selecting appropriate treatments, and the factors that 
influence this decision. Further details of its’ items and their origins can be 
found in Appendix D.  
There are three questions pertaining to feasibility and acceptability at the end of 
each self-report questionnaire. These address questionnaire length; 
understandability and relevance.  
Patient questionnaires will be given to participants to complete during their 
appointment with the main researcher, who will provide support, as required. 
Clinician questionnaires will be administered as described under ‘Recruitment 
Procedures’.  
The total number of patients assessed by and discharged from PTOP within the 
recruitment period will be recorded, along with the number of patients to 
progress through each recruitment stage (as outlined below). Reasons for 
refusal/ineligibility will be recorded, where appropriate. 
Recruitment stages: 
1. Patient informed of study by group facilitator/treating clinician 
2. Patient agreed researcher can contact them 
3. Patient telephone screened by researcher 
4. Patient attended appointment with researcher 




Sociodemographic information (age, gender, reason for referral and previous 
experience of psychological therapy) will be collected for patient participants 
during their appointment with the researcher. 
Data Analysis 
Data analysis will be largely descriptive as we aim to describe the feasibility 
and acceptability of the self-report questionnaires. Descriptive information 
regarding the sociodemographic characteristics of patient participants will be 
summarised and all data will be stored and analysed using SPSS. Each study 
question will be addressed in turn (referred to by their assigned number under 
‘Study Questions’ above). 
Q1. Recruitment rates, refusal rates and the proportion of patients lost at each 
recruitment stage will be calculated. Reasons for refusal or ineligibility will be 
presented alongside this data.  
Q2. Descriptive statistics of participant responses regarding the length, 
understandability and relevance of the questionnaires will be presented.  
Q3, 4 and 5. Exploratory data analyses will be conducted with the data 
gathered from participants’ responses on the questionnaires to obtain initial 
indications of response distributions.  
Justification of Sample Size 
Due to the nature of this study and its aim to explore the feasibility of recruiting 
eligible participants, no formal sample size calculations are required in line with 




participants, as previously recommended for feasibility studies (Browne, 1995), 
is likely to be sufficient to address the research questions.  
It is hoped that all 15 PTOP clinicians who deliver psychological therapy will be 
recruited as participants. Also see the contingency process outlined under 
‘Recruitment Procedures’. 
SETTINGS/EQUIPMENT 
Appointments between the researcher and patient participants will be held in 
NHSL clinic rooms, in the same location as the participants’ group/individual 
therapy (where possible).  
Equipment Required Source 
Patients  
PIS and Consent Forms Printing Costs 
Self-report questionnaires Printing Costs 
Clinicians  
PIS and Consent Forms Via email 
Self-report questionnaire Free survey build website 
 
HEALTH AND SAFETY ISSUES 
Researcher Safety 
Data collection will take place on NHSL sites and within working hours when 
other staff are available in the building. The researcher is familiar with local 





Study procedures will be carried out within NHSL settings that are designed to 
meet NHSL health and safety regulations, and, where possible, will be familiar 
to individual patients.  
There is a small possibility that the topic of investigation could be emotive to 
participants. They will be informed that they may take a break, or withdraw, 
from the study at any point. The researcher is trained in dealing with mental 
health related distress and will be able to assess for any presenting risk. If, 
during their contact with the researcher, participants present with active risk to 
themselves and/or others, the PTOP risk assessment and management 
protocol will be followed.  
ETHICAL ISSUES 
The procedure of this study is not associated with significant distress. The PIS 
will detail the study, patient confidentiality and anonymity, and written/online 
consent will be sought from all participants. Patients’ capacity to consent to and 
participate in this study will be continuously assessed throughout the duration 
of their contact with PTOP and the Researcher, in line with the Adults with 
Incapacity (Scotland) Act 2000. Confidentiality and its limits will be introduced 
at the start of psychological therapy, and participants will be informed that they 
can opt out or leave the study at any time, with no repercussions.  
Data will be managed in accordance with the Data Protection Act 2018, 
Caldicott Principles and guidance outlined in NHS Scotland’s Confidentiality 
Code of Practice Guidelines (2012).   





Considering patient preferences when designing and selecting treatments 
facilitates the delivery of true EBP, realistic medicine and person-centred care. 
This study’s findings will inform researchers and clinicians of the feasibility and 
acceptability of using questionnaires to elicit OA’ preferences and collect data 
on clinicians’ decision-making. This information, alongside the preliminary 
analyses of participant responses to the questionnaires, will inform whether 
proceeding with a pilot study (focused on analysing questionnaire data) is 
advisable and will allow for revision of the questionnaires, as required. 
Consequently, if the questionnaires are deemed feasible, this study will help 
services better understand what OAs prioritise when seeking treatment and 
what they think about psychological treatment options.  
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Appendix 2.2 Project Approval Letters 
 
 
             
Professor Hamish McLeod 
Mental Health and Wellbeing, University of Glasgow 
1st Floor, Administration Building 




West of Scotland REC 3 
Research Ethics  




Paisley PA2 7DE 
  
Date 30 October 2020 













Dear Professor McLeod  
 
Study title: A feasibility study examining treatment and outcome 
preferences of older adults (OAs) with mental health 
difficulties during COVID-19 and the effects of 
preferences on clinician decisions about treatment. 
REC reference: 20/WS/0143 
Protocol number: 4 
IRAS project ID: 281149 
 
The Research Ethics Committee reviewed the above application at the meeting held on 22 




The members of the Committee present gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting 
documentation, subject to the conditions specified below. 
 
 
Conditions of the favourable opinion 
 
The REC favourable opinion is subject to the following conditions being met prior to the start 
of the study.   
 
Please note:  This is the 
favourable opinion of the 
REC only and does not allow 
you to start your study at NHS 
sites in England until you 
receive HRA Approval  
 
WoSRES 






Number Condition Response from the applicant 
(this table may be copied and 
pasted into the response 
letter from the applicant 




In the letter to participants, there is 
a typographical error in the first 
a ag a h ( be ele h ne ). Thi  
should be amended. 
 
Clean and tracked copies of 
updated documents should be 




The REC also made the following recommendations. 
 
   
Number Recommendation Response from the applicant 
(this table may be copied and 
pasted into the response 
letter from the applicant 




In the Clinical Decision-Making 
Questionnaire, question 26 ( Build 
kindness and compassion; learn 
a   be le  c i ical f me. ) 







You should notify the REC once all conditions have been met (except for site 
approvals from host organisations) and provide copies of any revised documentation 
with updated version numbers. Revised documents should be submitted to the REC 
electronically from IRAS. The REC will acknowledge receipt and provide a final list of 
the approved documentation for the study, which you can make available to host 
organisations to facilitate their permission for the study. Failure to provide the final 
versions to the REC may cause delay in obtaining permissions. 
 
Confirmation of Capacity and Capability (in England, Northern Ireland and Wales) or NHS 
management permission (in Scotland) should be sought from all NHS organisations involved 
in the study in accordance with NHS research governance arrangements. Each NHS 
organisation must confirm through the signing of agreements and/or other documents that it 
has given permission for the research to proceed (except where explicitly specified 
otherwise).  
 
Guidance on applying for HRA and HCRW Approval (England and Wales)/ NHS permission 
for research is available in the Integrated Research Application System. 
For non-NHS sites, site management permission should be obtained in accordance with the 






Sponsors are not required to notify the Committee of management permissions from host 
organisations. 
 
Registration of Clinical Trials 
 
It is a condition of the REC favourable opinion that all clinical trials are registered on a 
b ic  acce ib e da aba e. F  hi  e, c i ica  ia  a e defi ed a  he fi  f  
project categories in IRAS project filter question 2. Registration is a legal requirement for 
clinical trials of investigational medicinal products (CTIMPs), except for phase I trials in 
healthy volunteers (these must still register as a condition of the REC favourable opinion). 
 
Registration should take place as early as possible and within six weeks of recruiting the first 
research participant at the latest. Failure to register is a breach of these approval conditions, 
unless a deferral has been agreed by or on behalf of the Research Ethics Committee ( see 
here for more information on requesting a deferral: https://www.hra.nhs.uk/planning-and-
improving-research/research-planning/research-registration-research-project-identifiers/  
 
As set out in the UK Policy Framework, research sponsors are responsible for making 
information about research publicly available before it starts e.g. by registering the research 




You should notify the REC of the registration details.  We routinely audit applications for 
compliance with these conditions.  
 
Publication of Your Research Summary 
 
We will publish your research summary for the above study on the research summaries 
section of our website, together with your contact details, no earlier than three months from 
the date of this favourable opinion letter.   
 
Should you wish to provide a substitute contact point, make a request to defer, or require 
further information, please visit: https://www.hra.nhs.uk/planning-and-improving-
research/application-summaries/research-summaries/ 
 
N.B. If your study is related to COVID-19 we will aim to publish your research 
summary within 3 days rather than three months.  
 
During this public health emergency, it is vital that everyone can promptly identify all relevant 
research related to COVID-19 ha  i  a i g ace g ba . If  ha e  a ead  d e , 
please register your study on a public registry as soon as possible and provide the HRA with 
the registration detail, which will be posted alongside other information relating to your 
project. We are also asking sponsors not to request deferral of publication of research 
summary for any projects relating to COVID-19. In addition, to facilitate finding and extracting 
studies related to COVID-19 from public databases, please enter the WHO official acronym 
for the coronavirus disease (COVID-19) in the full title of your study. Approved COVID-19 




It is the responsibility of the sponsor to ensure that all the conditions are complied 







After ethical review: Reporting requirements 
 
T e a ac ed d c e  Af e  e ca  e e   da ce f  e ea c e  e  de a ed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Notification of serious breaches of the protocol 
 Progress and safety reports 
 Notifying the end of the study, including early termination of the study 
 Final report 
 
The latest guidance on these topics can be found at https://www.hra.nhs.uk/approvals-
amendments/managing-your-approval/.  
 




The favourable opinion applies to all NHS/HSC sites taking part in the study taking part in the 
study, subject to confirmation of Capacity and Capability (in England, Northern Ireland and 
Wales) or NHS management permission (in Scotland)being obtained from the NHS/HSC 
R&D ff ce   e a  f e d  ( ee C d  f e fa ab e  be ).  
 
Non-NHS/HSC sites  
  
I am pleased to confirm that the favourable opinion applies to any non NHS/HSC sites listed 
in the application, subject to site management permission being obtained prior to the start of 




The documents reviewed and approved at the meeting were: 
 
Document   Version   Date   
IRAS Application Form [IRAS_Form_21092020]    15 September 2020  
Letter from sponsor [NHS Lanarkshire R&amp;D Sponsor 
Confirmation_L20037]  
NA  01 April 2020  
Letters of invitation to participant [Letter to Patients]  1  10 August 2020  
Non-validated questionnaire [Clinician Decision-Making 
Questionnaire]  
2  04 May 2020  
Non-validated questionnaire [Clinician Decision Making 
Questionnaire - Manual]  
2  04 May 2020  
Non-validated questionnaire [Patient Preferences Questionnaire]  2  06 July 2020  
Non-validated questionnaire [Patient Preferences Questionnaire - 
Manual]  
2  06 July 2020  
Participant consent form [Consent Form - Patient Participant]  2  06 July 2020  
Participant consent form [Consent Form - Clinician Participant]  2  06 July 2020  
Participant information sheet (PIS) [Participant Information Sheet - 
Patients]  
3  10 August 2020  
Participant information sheet (PIS) [Participant Information Sheet - 
Clinicians]  
3  10 August 2020  
Referee's report or other scientific critique report [Independent Blind 
Review and Related Correspondence]  






Document   Version   Date   
Referee's report or other scientific critique report [DClinPsy - 
Proceed to ethics letter]  
NA  07 February 2020  
Referee's report or other scientific critique report [NHS Lanarkshire 
Peer Review Assessment Form]  
NA  15 July 2020  
Research protocol or project proposal [Protocol]  4  04 September 2020  
Summary CV for Chief Investigator (CI) [McLeod - Brief CV - IRAS]  1  21 September 2020  
Summary CV for student [Principal Investigator CV]  1  13 July 2020  
 
 
Membership of the Committee 
 
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet. 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating Procedures for 




The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received 
and the application procedure. If you wish to make your views known please use the 
feedback form available on the HRA website: http://www.hra.nhs.uk/about-the-




We are pleased to welcome researchers and research staff to our HRA Learning Events and 
online learning opportunities  see details at: https://www.hra.nhs.uk/planning-and-improving-
research/learning/ 
 
IRAS project ID: 281149 Please quote this number on all correspondence 
 
 









on behalf of 










             
Miss Rachel Cross 
Institute of Health and Wellbeing, University of 
Glasgow 
1st Floor, Administration Building 




West of Scotland REC 3 
Research Ethics  




Paisley PA2 7DE 
  
Date 06 November 2020 
Direct 
line 















Dear Miss Cross 
 
Study title: A feasibility study examining treatment and outcome 
preferences of older adults (OAs) with mental health 
difficulties during COVID-19 and the effects of 
preferences on clinician decisions about treatment. 
REC reference: 20/WS/0143 
Protocol number: 4 
IRAS project ID: 281149 
 
Thank you for your letter of 05 November 2020.  I can confirm the REC has received the 
documents listed below and that these comply with the approval conditions detailed in our letter 
dated 30 October 2020 
 
Please note:  This is an 
acknowledgement letter from 
the REC only and does not 
allow you to start your study 
at NHS sites in England until 
you receive HRA Approval  
 
WoSRES 







The documents received were as follows: 
 
Document   Version   Date   
Letters of invitation to participant [Letter to Patients (Tracked)]  2  05 November 2020  
Letters of invitation to participant [Letter to Patients]  2  05 November 2020  
Non-validated questionnaire [Patient Preferences Questionnaire 
(Tracked)]  
3  05 November 2020  
Non-validated questionnaire [Patient Preferences Questionnaire]  3  05 November 2020  
Protocol [Protocol (Tracked)]  5  05 November 2020  
Research protocol or project proposal [Protocol]  5  05 November 2020  




The final list of approved documentation for the study is therefore as follows: 
 
Document   Version   Date   
IRAS Application Form [IRAS_Form_21092020]    15 September 2020  
Letter from sponsor [NHS Lanarkshire R&amp;D Sponsor 
Confirmation_L20037]  
NA  01 April 2020  
Letters of invitation to participant [Letter to Patients (Tracked)]  2  05 November 2020  
Letters of invitation to participant [Letter to Patients]  2  05 November 2020  
Non-validated questionnaire [Patient Preferences Questionnaire 
(Tracked)]  
3  05 November 2020  
Non-validated questionnaire [Patient Preferences Questionnaire]  3  05 November 2020  
Participant consent form [Consent Form - Patient Participant]  2  06 July 2020  
Participant consent form [Consent Form - Clinician Participant]  2  06 July 2020  
Participant information sheet (PIS) [Participant Information Sheet - 
Patients]  
3  10 August 2020  
Participant information sheet (PIS) [Participant Information Sheet - 
Clinicians]  
3  10 August 2020  
Protocol [Protocol (Tracked)]  5  05 November 2020  
Referee's report or other scientific critique report [Independent Blind 
Review and Related Correspondence]  
NA  29 January 2020  
Referee's report or other scientific critique report [DClinPsy - 
Proceed to ethics letter]  
NA  07 February 2020  
Referee's report or other scientific critique report [NHS Lanarkshire 
Peer Review Assessment Form]  
NA  15 July 2020  
Research protocol or project proposal [Protocol]  5  05 November 2020  
Response to Additional Conditions Met    05 November 2020  
Summary CV for Chief Investigator (CI) [McLeod - Brief CV - IRAS]  1  21 September 2020  
Summary CV for student [Principal Investigator CV]  1  13 July 2020  
 
You should ensure that the sponsor has a copy of the final documentation for the study.  It is 





at all participating sites. 
 









Copy to: Prof Hamish McLeod 
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                                                                                                                                                                                                                                   Cont... 
Dr Hamish McLeod 
University of Glasgow 
Institute of Mental Health and Wellbeing 






Corporate Services Building 
University Hospital Monklands  




 Date    16/Nov/2020  
 Enquiries to Cynthia Dolier, R&D Facilitator 
 Direct Line  01236 712460 
 Email   cynthia.dolier@lanarkshire.scot.nhs.uk   
 
Dear Dr McLeod 
 
Project title: A feasibility study examining treatment and outcome preferences of older adults (OAs) with  
mental health difficulties during COVID-19 and the effects of preferences on clinician decisions 
about  treatment 
 
R&D ID:  L20037 
 
I am writing to you as Chief Investigator of the above study to advise that R&D Management approval has been granted 




As you are aware, NHS Lanarkshire has agreed to be the Sponsor for your study. On its behalf, the R&D Department has 
a number of responsibilities; these include ensuring that you understand your own role as Chief Investigator of this 
study. To help with this we have outlined the responsibilities of the Chief Investigator in the attached document for you 
information. 
 
All research projects within NHS Lanarkshire will be subject to annual audit via a questionnaire that we will ask you to 
complete. In addition, we are required to carry out formal monitoring of a proportion of projects, in particular those 
projects that are Sponsored by NHS Lanarkshire. In either case, you will find it helpful to maintain a well organised Site 
File. You may find it helpful to use the folder that we have included for that purpose.    
  
NAME TITLE  ROLE NHSL SITE TO WHICH APPROVAL APPLIES  














For the study to be carried out you are subject to the following conditions:  
 
x You are required to comply with Good Clinical Practice, Ethics Guidelines, Health & Safety Act 1999 and relevant UK 
and EU Data Protection legislation. 
x The research is carried out in accordance with the Scottish Executive’s Research Governance Framework for Health 
and Community Care (copy available via the Chief Scientist Office website: http://www.show.scot.nhs.uk/cso/  or 
the Research & Development Intranet site: http://firstport/sites/randd/default.aspx. 
x You must ensure that all confidential information is maintained in secure storage. You are further obligated under 
this agreement to report to the NHS Lanarkshire Data Protection Office and the Research & Development Office 
infringements, either by accident or otherwise, which constitutes a breach of confidentiality. 
x Clinical trial agreements (if applicable), or any other agreements in relation to the study, have been signed off by all 
relevant signatories. 
x You must contact the Lead Nation Coordinating Centre if/when the project is subject to any minor or substantial 
amendments so that these can be appropriately assessed, and approved, where necessary. 
x You notify the R&D Department if any additional researchers become involved in the project within NHS Lanarkshire 
x You notify the R&D Department when you have completed your research, or if you decide to terminate it 
prematurely. 
x You must send brief annual reports followed by a final report and summary to the R&D office in hard copy and 
electronic formats as well as any publications. 
x If the research involves any investigators who are not employed by NHS Lanarkshire, but who will be dealing with 
NHS Lanarkshire patients, there may be a requirement for an SCRO check and occupational health assessment.  If 
this is the case then please contact the R&D Department to make arrangements for this to be undertaken and an 
honorary contract issued. 
 






Raymond Hamill – Senior R&D Manager 
 
c.c. 
NAME TITLE CONTACT ADDRESS ROLE 
Rachel Cross Trainee Clinical Psychologist Rachel.Cross@lanarkshire.scot.nhs.uk  
r.cross.1@research.gla.ac.uk 
Principal Investigator  
Dr Philip Smith  Clinical Psychologist philipsmith3@nhs.net  Sponsor Contact 
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Responsibilities as Sponsor  
 
Site File  
As an aid to the conduct of your study we will provide a Site File that Rachel may wish to use. As Sponsor of the 
study we are required to carry out audit of all project, and to conduct detailed monitoring visits for a proportion 
(approximately 10%) - The study Site File should help you ensure that you have the relevant documentation to 
assist in this process. If your project is selected for monitoring, we will contact you well in advance to arrange a 
suitable time. 
Our responsibilities as Sponsor are defined within the Research Governance Framework for Health and 
Community Care. A summary of these, along with those of the Chief Investigator, is provided in the following 
table for your information.  
 
RESPONSIBILITIES OF CHIEF INVESTIGATOR NHSL RESPONSIBILITIES AS SPONSOR  
Obtain relevant / appropriate Research Ethics opinion. 
 
Obtain NHSL Research Management Approval. 
 
Ensure that the members of the research team have the necessary 
expertise, experience and education to perform their roles.  
 
Ensure the necessary resources are available for the study. 
 
Act in accordance with regulations set out by your professional 
body(s) and the conditions of your employment contract. 
 
Identify archiving arrangements at the study outset. 
 
Record and review significant developments that may affect the 
study, particularly those which put the safety of the individuals at 
risk or affect the scientific direction and report to the sponsor as 
appropriate. 
 
Record, report and review all untoward medical occurrence 
(adverse events or reactions) including classification of causality, 
seriousness and expectedness. 
 
Notify R&D and appropriate REC of significant news, changes, 
amendments and modifications to the study. 
 
Maintain a record of all incidents, providing an annual report to 
the sponsor. 
 
Inform REC and R&D of the study end. 
  
Maintain a log of archived documents and their location. 
 
Inform R&D of any publications arising from the study or 
dissemination of findings. 
  
Inform R&D of any potential Intellectual Property.   
Assess adequateness of the independent, expert 
review. 
 
Ensure that the Chief/Principle Investigator has the 
necessary expertise, experience and education to 
conduct the study. 
 
Provide a formal written agreement of sponsorship 
conditions, and notification of confirmation of the 
sponsorship role. 
 
Provide NHS indemnity to the Chief Investigator and 
research team. 
 
Provide mechanisms and processes to exploit any 
potential Intellectual Property.  
 
Project monitoring commensurate with risk. 
 
Make available local, national and international 
guidelines, regulations and legislation governing 
research in the UK. 
 
Provide ongoing advice and guidance to promote 
quality study management and conduct. 
 
Determine the acceptability of the archive 
arrangements proposed by the Chief Investigator and, 
if the archive facility becomes unsuitable, provide 
alternative arrangements. 
 
Determine length of archive/retention period for 
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Headq ar ers: Ass n  Ho se, Beech ood Park, INVERNESS  IV2 3BW 
 
Chair: Professor Bo d Rober son 
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D    C , 
 
Management Approval for Non-Commercial Research 
 
 
I acknowledge that: 
 
x The project is sponsored by NHS Lanarkshire. 
x The project has no external funding. 
x Ethics approval for the project has been obtained from the West of Scotland 
Research Ethics Committee (Reference Number: 20/WS/0143)  
x The project has a signed Organisational Information Document.  
 
The following conditions apply:       
 
x The responsibility for monitoring and auditing this project lies with NHS Lanarkshire. 
Ms Rachel Cross,  
Trainee Clinical Psychologist  
Institute of Health and Wellbeing, University of Glasgow 
1st Floor, Administration Building 






I am pleased to tell you that you now have Management Approval for the research project 
entitled: A feasibility study examining treatment and outcome preferences of older 
adults (OAs) with mental health difficulties during COVID-19 and the effects of 








x This study will be subject to ongoing monitoring for Research Governance purposes 
and may be audited to ensure compliance with the UK Policy Framework for Health 
and Social Care Research (2018, V3.3 07/11/17, however prior written notice of 
audit will be given. 
x Any researchers coming into NHS Highland for the purposes of carrying out 
research with patients will require a Letter of Access before starting the study at this 
site. Please contact a member of the RD&I Governance team at 
nhsh.nhshighlandresearchpassports@nhs.scot for further assistance, if this is 
required. 
x The paperwork concerning all incidents, adverse events and serious adverse 
events thought to be attributable to a a c a     c   
be notified to the NHS Highland RD&I Governance team. Please email documents 
to RD&I Facilitator at nhsh.RandD@nhs.scot.  
x You are reminded that all amendments (substantial or non-substantial) to the 
protocol and associated study documents or to the REC application should be 
notified to the NHS Highland RD&I Office to obtain amendment approval 
(nhsh.RandD@nhs.scot). Guidance can be found at 
https://www.nhsresearchscotland.org.uk/services/permissions-co-ordinating-
centre/permissions 
x If applicable, monthly recruitment rates should be notified to the NHS Highland 
RD&I Office, detailing date of recruitment and the participant trial ID number. This 
should be done by e-mail on the first week of the following month, to Debbie 
McDonald, Data Manager (deborah.mcdonald@nhs.scot). Please quote your RD&I 
Highland reference number (Highland 1705).  
x Please report any other changes in resources used, or staff involved in the project, 
to the NHS Highland RD&I Office (nhsh.RandD@nhs.scot).  
 
Please quote your RD&I Highland reference number (Highland 1705) on all 
correspondence. 
 





cc  Jo Fraser, RD&I Administration Assistant, NHS Highland Research, Development & 
Innovation Division, Ground Floor Phase 3, Centre for Health Science, Old Perth 
Road, Inverness, IV2 3JH 
 
 Professor Hamish McLeod, Institute of Health and Wellbeing 
University of Glasgow, 1st Floor Administration Building, Gartnavel Royal Hospital, 
1055 Great Western Road  G12 0XH hamish.mcleod@glasgow.ac.uk 
 
Jim Law, Consultant Clinical Neuropsychologist, Head of Clinical Psychology 
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Administrator: Mr Scott Broadley 




 Research & Innovation 
Dykebar Hospital, Ward 11 
Grahamston Road 




12 November 2020 
 
Miss Rachel Cross 
Institute of Health and Wellbeing 
University of Glasgow 
1st Floor, Administration Building 
Gartnavel Royal Hospital,  
1055 Great Western Road, G12 0XH 
 
NHS GG&C Board Approval 
 
Dear Miss Rachel Cross, 
 
Study Title:  OA ' preference  and heir effec  on clinician  deci ion-making 
Principal Investigator:   Miss Rachel Cross 
GG&C HB site Belmont Centre - Stobhill Hospital 
Sponsor NHS Lanarkshire 
R&D reference: GN20MH494 
REC reference: 20/WS/0143 
Protocol no: 
(including version and 
date) 
Version 5, 05/11/2020 
 
I am pleased to confirm that Greater Glasgow & Clyde Health Board is now able to grant Approval for the above 
study. 
 
Conditions of Approval 
1. For Clinical Trials as defined by the Medicines for Human Use Clinical Trial Regulations, 2004 
a. During the life span of the study GGHB requires the following information relating to this site 
i. Notification of any potential serious breaches. 
ii. Notification of any regulatory inspections. 
 
It is your responsibility to ensure that all staff involved in the study at this site have the appropriate GCP training 
according to the GGHB GCP policy (www.nhsggc.org.uk/content/default.asp?page=s1411), evidence of such 
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2. For all studies the following information is required during their lifespan. 
a. First study participant should be recruited within 30 days of approval date. 
b. Recruitment Numbers on a monthly basis 
c. Any change to local research team staff should be notified to R&D team 
d. Any amendments ± Substantial or Non Substantial 
e. Notification of Trial/study end including final recruitment figures 
f. Final Report & Copies of Publications/Abstracts 
g. You must work in accordance with the current NHS GG&C COVID19 guidelines and principles. 
 
Please add this approval to your study file as this letter may be subject to audit and monitoring. 
 
Your personal information will be held on a secure national web-based NHS database. 






Mr Scott Broadley 
































Appendix 2.3 Participant information sheet for patients (V3, 10/08/2020) 
 
 
Participant Information Sheet – Patient Participant 
Study Title: Older adults’ preferences and their effects on 
clinicians’ decision-making 
Who is conducting the research?  
This study is being carried out by:  
• Rachel Cross, Trainee Clinical Psychologist and Principal 
Investigator (University of Glasgow, NHS Lanarkshire)  
• Prof Hamish McLeod, Chief Investigator and Professor of Clinical 
Psychology (University of Glasgow)  
• Dr Philip Smith, Clinical Psychologist and Local Lead 
Collaborator (NHS Lanarkshire)  
Invitation  
You are invited to take part in a research study. Before you decide if 
you would like to participate it is important for you to understand 
why the research is being done and what it will involve. Please read 
the following information carefully and discuss it with others if you 
wish. One of the researchers will go through this information sheet 
with you and answer any questions you have. This can be done on 
the phone or by video call and should take about 15 minutes. It is 
important that you take the time you need to decide whether or not 
you wish to take part.  
What is the purpose of the study?  
Patients hold preferences about what psychological therapy should 
involve, how their therapist should behave and what they want to 
gain from therapy. Research suggests that accommodating these 
treatment and outcome preferences can have a positive impact on 
attendance at therapy appointments and clinical outcomes. 
However, there is currently no agreed upon method for eliciting 
patient preferences and they are often overlooked by Clinicians 




explore whether it is possible to use questionnaires to elicit older 
adults’ treatment and outcome preferences and to determine 
whether clinicians consider these preferences when selecting 
treatment.  
Older adults are disproportionately likely to be affected by measures 
implemented by the UK government to contain the spread of 
COVID-19. Physical distancing and self-isolation measures may 
impact on older adults’ mental health and could therefore influence 
their treatment and outcome preferences for psychological therapy. 
Government restrictions on face-to-face contact also led 
psychological services to adopt remote delivery of psychological 
therapies (i.e. delivery via telephone or video calls). We have 
designed this study with these changes in mind. We hope to 
increase understanding of how older adults want to be seen and 
treated and what they hope to gain from therapy, during COVID-19. 
We also want to identify any additional difficulties faced by 
clinicians, given the current circumstances, when trying to consider 
and accommodate patient preferences.   
Why have I been invited?  
We are looking for participants accessing NHS Lanarkshire mental 
health services for older people because they are experiencing a 
psychological problem. Participants can either be about to begin, 
currently receiving or recently finished group or individual 
psychological therapy. We asked clinicians who deliver 
psychological therapies to identify people who may be interested in 
taking part in this research.  
Do I have to take part?  
No, participation is voluntary and it is up to you to decide whether or 
not to take part. If you decide to participate, you will be asked to 
sign a consent form. You are free to withdraw from the study at any 
time and without giving a reason. We will not use data from 
questionnaires where the participant has chosen to withdraw. 
Deciding not to take part or withdrawing from the study will not 
affect any treatment that you are currently receiving or any that you 
may need in the future.  
What would taking part involve?  
If you decide to take part, you will be invited to complete a 




psychological therapy. You will be asked to rate your preferences 
using a scale. Please note that some of the treatment options listed 
in the questionnaire may not be available or suitable for your 
difficulties. We will also ask for some information about you (e.g. 
age, gender, reason for seeking treatment) and your experience of 
completing the questionnaire. It will take approximately 25 minutes 
to answer all the study questions.  
You will be given a choice of completing the questionnaire 
electronically (via the internet or email) or on paper (sent to you in 
the mail). If you opt for paper copies, you will be sent a stamped 
envelope to return the forms by post. Please note, if you are 
currently ‘shielding’ due to COVID-19 you may need someone else 
to post these documents on your behalf. Regardless of how you 
choose to participate, you will be asked to read and sign a consent 
form before starting the questionnaire.  
What are the disadvantages and risks of taking part?  
There are minimal risks associated with taking part. There is a time 
burden, as we ask you to complete a questionnaire. When filling it 
out, difficult thoughts or feelings may arise when thinking of the 
answers. Similarly, you may experience some emotional distress 
when thinking about what you hope will be different after 
psychological therapy. These reactions are all within the scope of 
the kinds of experiences that people referred for psychological 
therapy experience. If you become distressed while completing the 
questionnaire, please feel free to withdraw. If you become 
distressed as a result of completing this study, we suggest that you 
contact NHS24 (telephone 111) or your healthcare provider.  
What are the possible benefits of taking part?  
There are no direct benefits to you personally. Some people find the 
experience of participating in research interesting and some people 
enjoy contributing to the accumulation of new knowledge. The 
information you give will be used to improve mental health services 
in the future.   
Will my taking part in this study be kept confidential?  
All information collected for the duration of this study will be kept 
strictly confidential.   You will be assigned an anonymous participant 
ID, which will be used in place of your name throughout the study so 




Data will be stored on a password protected and encrypted 
computer and only the researchers will have access to the 
anonymised data. Any record of your personal information (e.g. 
home or email address) will be destroyed at the end of the study. 
What will happen to the results of the study?  
The results of the study will be written into a report and submitted to 
the University of Glasgow as part of Rachel Cross’s requirements 
for the Doctorate in Clinical Psychology. It is possible that this report 
will also be published in an academic journal. A summary of this 
report will be distributed to the older adult mental health teams 
within NHS Lanarkshire, which can be shared with you if you are 
interested in knowing the results of the study.  
Who is organising and funding this research?  
The research is organised via the University of Glasgow and is 
supported by NHS Lanarkshire. There is no commercial funding 
associated with this research. 
Who has reviewed the study? 
All research in the NHS is reviewed by an independent group of 
people called a Research Ethics Committee to protect your 
interests. The West of Scotland Ethics Committee has reviewed this 
study and favourable opinion has been given.  
If you have any further questions  
If you have any further questions or concerns about the study, 
please contact the main researcher, using the contact details 
provided below.  
If you would like more information about the study and wish to 
speak with someone who is not closely linked to the study, please 
contact Dr Breda Cullen, DClinPsy Programme Research Director, 
University of Glasgow, email: Breda.Cullen@glasgow.ac.uk. 
If you have a complaint about any aspect of the study  
If you are unhappy about any aspect of the study and wish to make 
a complaint, please contact the main researcher in the first instance. 
The normal NHS complaint procedure is also available for you. The 
contact person for making a complaint in NHS Lanarkshire is: Laura 
Jack, NHS Lanarkshire Headquarters, Kirklands Hospital, Fallside 





Contact details  
If you would like further information, you can contact:  
Rachel Cross, Trainee Clinical Psychologist and Main Researcher 
Institute of Health and Wellbeing – University of Glasgow 
1st Floor, Admin Building 
Gartnavel Royal Hospital 
1055 Great Western Rd  
Glasgow, G12 0XH 






Appendix 2.4 Consent form for patients (V2, 06/07/2020) 
 
 
Patient Participant Consent Form 
 
Study Title:  Older adults' preferences and their effects on 
clinicians’ decision-making 
Researchers:  Rachel Cross, Prof Hamish McLeod, Dr Philip Smith 
Contact Details: Mental Health & Wellbeing – University of Glasgow 
1st Floor, Administration Building 
Gartnavel Royal Hospital  
1055 Great Western Road  
Glasgow, G12 0XH  
Email: r.cross.1@research.gla.ac.uk 
 
Please read and initial the following statements to ensure you 
understand all the information before proceeding.  
 Initial in 
box 
1. I have read and understood the Participant Information 
Sheet dated 10/08/2020 Version 3  for the above study. 
I have had the opportunity to consider the information, 
ask questions and have had these answered 
satisfactorily.  
 
2. I understand that my participation is voluntary and that 
I am free to withdraw at any time without giving any 
reason, and without my medical care or legal rights 
being affected. 
 
3. I understand that all data collected in this study will be 
anonymised and kept confidential.   
4. I agree to information about my age, gender, reasons 
for seeking treatment and previous experience of 
psychological therapy being collected. I understand that 





5. I understand that the anonymised data may be looked 
at by individuals from University of Glasgow and from 
regulatory authorities. 
 
6. I understand that the results of this study will be written 
into a report for others to read, but that no individual’s 
data will be outlined in this report.  
 
7. I agree to take part in this study.  
 
 
-----------------------    ------------------------- -----------------  
Name of Participant   Date     Signature  
 






Appendix 2.5 Participant information sheet for clinicians (V3, 10/08/2020) 
 
 
Participant Information Sheet – Clinician Participant 
Study Title: Older adults’ preferences and their effects on clinicians’ decision-
making 
Who is conducting the research?  
This study is being carried out by:  
• Rachel Cross, Trainee Clinical Psychologist and Principal Investigator 
(University of Glasgow, NHS Lanarkshire)  
• Prof Hamish McLeod, Chief Investigator and Professor of Clinical 
Psychology (University of Glasgow)  
• Dr Philip Smith, Clinical Psychologist and Local Lead Collaborator (NHS 
Lanarkshire)  
Invitation  
You are being invited to take part in a research study. Before you decide if you 
would like to take part it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the following 
information carefully. Contact details for the research team are provided below 
should you wish to ask any questions.  
What is the purpose of the study?  
Research suggests that patients hold preferences about what psychological 
therapy should involve, how their therapist should behave and what they want 
to gain from therapy. Accommodating these treatment and outcome 
preferences has been found to have a positive impact on psychological therapy 
attendance and outcomes. However, patient preferences are often not 
considered in clinical decision-making for various reasons, including there 
being no standardised method for eliciting them.  
This study will explore the feasibility and acceptability of using questionnaires to 
elicit older adults’ (OAs) treatment and outcome preferences and determine 
whether clinicians consider these preferences when selecting treatment.  
OAs are disproportionately likely to be affected by physical distancing and self-
isolation measures implemented by the UK government to contain the spread 
of COVID-19. These measures may have significant mental health implications 
and could therefore influence OA’s treatment and outcome preferences for 
psychological therapy. Government restrictions on face-to-face contact also led 




delivery via telephone or video calls). We have designed this study with these 
changes in mind. We hope to increase understanding of OAs’ treatment and 
outcome preferences during COVID-19 (including their preferences for remote 
service delivery), and identify any additional difficulties faced by clinicians, 
given the current circumstances, when trying to consider and accommodate 
patient preferences.   
Why have I been invited?  
We are looking for clinicians who provide psychological therapy to older adults 
(age 65 or over) with mental health difficulties. We are inviting (Trainee) Clinical 
Psychologists; (Trainee) Clinical Associates in Applied Psychology and 
CBT/Psychological Therapists to participate.  
Do I have to take part?  
No, participation is entirely voluntary. It is up to you to decide whether or not to 
take part. If you decide to participate, you will be asked to sign an online 
consent form. You are free to withdraw from the study by closing the online 
survey. You do not need to give a reason. We will not use data from surveys 
where the participant has chosen to withdraw.  
What would taking part involve?  
If you decide to take part, you are invited to complete an online questionnaire 
about factors that affect your clinical decision-making, which will take 
approximately 20 minutes to complete. We will also ask for sociodemographic 
data that has previously been shown to play a role in determining clinicians’ 
consideration of patient treatment and outcome preferences. You can access 
the questionnaire via the link provided in the invitation email, which will take you 
to the study webpage. Before completing the questionnaire, you will be asked 
to electronically sign an online consent form. All of the information you provide 
will be anonymous, your identity will be concealed and kept confidential.  
What are the disadvantages and risk of taking part?  
There is no risk of harm involved in taking part in this research project. There is 
a time burden associated with taking part as we ask you to complete a 
questionnaire.  
What are the possible benefits of taking part?  
There are no direct benefits. You may find the experience of taking part in 
research interesting or you might enjoy contributing to the accumulation of new 
knowledge about ways to improve service delivery. We hope that our findings 
will improve methods for understanding treatment and outcome preferences in 
older adults, which will help clinicians in services better understand what older 
adults prioritise when seeking treatment and what they think about 
psychological treatment options. This will facilitate the delivery of true evidence-
based practice.   
Will my taking part in this study be kept confidential?  
All information that is collected about you during the course of the research will 




responses are separated from your personally identifiable information. Data will 
be stored on a password protected and encrypted computer and only the 
researchers will have access to the anonymised data. 
What will happen to the results of the study?  
The results of the study will be written into a report and submitted to the 
University of Glasgow as part of Rachel Cross’ requirements for the Doctorate 
in Clinical Psychology. The final thesis will be available through the University 
of Glasgow’s Library and will be published on the University’s Enlighten service 
which is accessible to the wider public to promote research dissemination. It is 
possible that this report will also be published in an academic journal.  
Who is organising and funding this research?  
The research is organised via the University of Glasgow and is sponsored by 
NHS Lanarkshire. There is no commercial funding associated with this 
research. 
Who has reviewed the study? 
The West of Scotland Research Ethics Committee has reviewed this study and 
favourable opinion has been given.  
If you have any further questions  
If you have any further questions or concerns about the study, please contact 
the main researcher, using the contact details provided below.  
If you would like more information about the study and wish to speak with 
someone who is not closely linked to the study, please contact Dr Breda Cullen, 
DClinPsy Programme Research Director, University of Glasgow, email: 
Breda.Cullen@glasgow.ac.uk. 
If you have a complaint about any aspect of the study  
If you are unhappy about any aspect of the study and wish to make a 
complaint, please contact the researcher in the first instance. The University of 
Glasgow complaints procedure is also available to you. The contact person for 
making a complaint is Dr Breda Cullen, DClinPsy Programme Research 
Director, University of Glasgow, email: Breda.Cullen@glasgow.ac.uk.  
Contact details  
If you would like further information, you can contact:  
Rachel Cross, Trainee Clinical Psychologist and Main Researcher: 
Institute of Health and Wellbeing – University of Glasgow 
1st Floor, Admin Building 
Gartnavel Royal Hospital 
1055 Great Western Rd  
Glasgow, G12 0XH 
Tel: 01698 210021 




Appendix 2.6 Consent form for clinicians (V2, 06/07/2020) 
 
 
Clinician Participant Consent Form  
 
Study Title:  Older adults’ preferences and their effects on clinicians’ 
decision-making. 
Researchers:  Rachel Cross, Prof Hamish McLeod, Dr Philip Smith 
Contact Details: Mental Health & Wellbeing – University of Glasgow 
1st Floor, Administration Building 
Gartnavel Royal Hospital  
1055 Great Western Road  
Glasgow, G12 0XH  
Tel: 01698 210021 
Email: r.cross.1@research.gla.ac.uk 
 
Please read and tick the following statements to ensure you understand all the 
information before proceeding.  
1. I have read and understood the Participant Information Sheet 
dated  10/08/2020  Version 3  for the above study. I have had the 
opportunity to consider the information, ask questions and have 
had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time without giving any reason.  
3. I understand that all data collected in this study will be 
anonymised and kept confidential.   
4. I understand that the anonymised data may be looked at by 
individuals from University of Glasgow and from regulatory 
authorities. 
 
5. I understand that the results of this study will be written into a 
report for others to read, but that no individual’s data will be 
outlined in this report.  
 
6. I consent to taking part in this study.  
 
 
-----------------------    -------------------------   -----------------  





Appendix 2.7 Clinician demographics questionnaire 
Participant ID Number:        
Date:          
The following Sociodemographic information is being collected as previous 
research has associated it with clinical decision-making. Please answer the 
following questions in turn.  
 
What is your highest professional qualification? Please place a cross (X) in 
the box to the right of the response alternative that suits best. Choose only one 
response.  
 
Highest Professional Qualification Cross (X) 
Undergraduate degree  
Master’s degree  
Postgraduate Diploma (without the 
requirement for independent research) 
 
Doctorate (research)  
Doctorate in Clinical Psychology  
Doctorate in Counselling Psychology  
Other  
If other please state: 
 
How many years of clinical experience do you have of delivering 
psychological therapy?                  
 
What is the main therapy modality that you use when delivering individual 
therapy? Please place a cross (X) in the box to the right of the response 
alternative that suits best. Choose only one response. 
 
Main Therapy Modality Cross (X) 
Cognitive Behavioural Therapy  
Compassion Focused Therapy  
Acceptance Commitment Therapy  
Psychodynamic Psychotherapy  
Schema Therapy  
Eclectic or integrative mix  
Humanistic  






Appendix 2.8 Patient Preferences Questionnaire (PPQ) 
Participant ID Number:        
Date:          
This questionnaire contains a number of statements regarding the hopes and 
desires one can have before and during psychotherapy. Read each statement 
in turn and consider to what extent you agree or disagree at the present time. In 
other words, think about how well each statement fits with your current 
preferences. Please place a cross (X) in the box under the response alternative 
that suits best. Only choose one response for each statement.  
The question for you to consider is: What would you prefer if you were in 
psychotherapy?  
Example: 
In psychotherapy, I 
would prefer to: 
 
 
 I agree… 




Somewhat Moderately Quite 
a lot 
Completely  
Talk about things that 
are bothering me 
 
   X   
 
Treatment Options - What would you prefer if you were in psychotherapy? 
In psychotherapy, I 
would prefer to: 
I agree… 




Somewhat Moderately Quite 
a lot 
Completely  
1.  Have weekly or 
fortnightly telephone 
contact with a 
therapist on a 1-to-1 
basis.  
      
2.  Have weekly or 
fortnightly video call 
contact with a 
therapist on a 1-to-1 
basis.  
      
3.  Have weekly or 
fortnightly face-to-
face contact with a 
therapist on a 1-to-1 
basis, in a clinic 
setting. 




In psychotherapy, I 
would prefer to: 
I agree… 




Somewhat Moderately Quite 
a lot 
Completely  
4.  Have weekly or 
fortnightly face-to-
face contact with a 
therapist on a 1-to-1 
basis, at my home. 
      
5.  Enter a group 
therapy that is held 
weekly over video 
call, where I will be 
taught skills to cope 
with my difficulties.  
      
6.  Work through 
written booklets to 
help me cope with 
my difficulties, with 
occasional 
telephone or video 
call support from a 
professional. 
      
7.  Access a course of 
self-help through a 
computer to teach 
me to notice and 
change unhelpful 
patterns of thoughts, 
feelings and 
behaviours. 
      
8.  Have a male 
therapist 
      
9.  Have a female 
therapist 
      
10.  Have a therapist 
who gives me 
advice 
 
      
11.  Have a therapist 
who provides 
practical support 
      
12.  Have a therapist 
who is non-
judgemental 
      
13.  Have a therapist 
who tells me what to 
do 




In psychotherapy, I 
would prefer to: 
I agree… 




Somewhat Moderately Quite 
a lot 
Completely  
14.  Have a therapist 
who validates my 
experiences  
      
15.  Have a therapist 
who listens to me 
and tries to 
understand  
      
16.  Notice and change 
unhelpful thoughts; 
learn to think 
differently 
      
17.  Notice and change 
unhelpful habits or 
patterns of 
behaviour 
      
18.  Learn to face 
situations that I fear 
or have been 
avoiding 
      
19.  Reflect on painful 
memories 
      
20.  Look at ways I could 
become more active 
      
21.  Learn strategies and 
skills to deal with 
problematic 
situations 
      
22.  Learn to take my 
thoughts less 
seriously and be 
less caught up in 
them 
      
23.  Learn to be ok with 
unwanted emotions, 
even if I can’t get rid 
of them completely 
      
24.  Learn meditation 
techniques 
      
25.  Clarify my values – 
what is important to 
me in life and what 
kind of person I 
want to be 




In psychotherapy, I 
would prefer to: 
I agree… 




Somewhat Moderately Quite 
a lot 
Completely  
26.  Build kindness and 
self-compassion 
      
27.  Learn ways to be 
less critical of me 
      
28.  Explore links 
between earlier life, 
including events in 
childhood, and how 
this affects my life 
presently 
      
29.  Learn skills for 
improving my 
relationships 
      
30.  Develop skills to 




      
31.  Talk over the course 
of my life, to put 
things in perspective 
and gain a sense of 
peace about the 
past 
      
32.  Explore the loss of a 
loved one 
      
33.  Talk about major life 
changes to help me 
adjust to them (e.g. 
retirement or self-
isolating due to 
COVID-19). 
      
 
Treatment Outcomes – What would you prefer to gain from 
psychotherapy? 
After completing 
psychotherapy, I would 
prefer to: 
I agree… 





Somewhat Moderately Quite 
a lot 
Completely  
34.  Have a sense of 
purpose and 
meaning in my life 





psychotherapy, I would 
prefer to: 
I agree… 





Somewhat Moderately Quite 
a lot 
Completely  
35.  Feel more hopeful       
36.  Like myself       
37.  Have more energy to 
do things 
      
38.  Have improved 
relationships with 
others 
      
39.  Feel less lonely       
40.  Have learned how to 
focus less on/worry 
less about my 
physical health 
      
41.  Feel more able to 
cope with uncertainty 
      
42.  Sleep better       
43.  Have more things to 
do in my week 
      
44.  Feel less troubled by 
memories from the 
past 
      
45.  Have learned to live 
with pain and other 
physical difficulties 
      
46.  Feel more confident       
47.  Be less bothered by 
worries 
      
48.  Have learned how to 
manage my nerves 
and uncomfortable 
feelings in my body 
(e.g. sickness in 
stomach)  
      
49.  Have made sense of 
my life 
      
50.  Have come to terms 
with the loss of 
somebody 





psychotherapy, I would 
prefer to: 
I agree… 





Somewhat Moderately Quite 
a lot 
Completely  
51.  Have adjusted to 
major life changes 
(e.g. retirement) 
      
 
Please answer the following questions about your experience of 
completing this questionnaire. Tick the box that best suits your experience of 
completing the questionnaire. Choose only one response.  
 
1. The length of this questionnaire was:  
Too long ☐  Too short ☐  Just right ☐ 
2. The questions asked above seemed relevant to me and my circumstances: 
Yes ☐  No ☐  Sort of ☐ 
3. How easy was it to understand the questions and what was being asked of 
you? 





Appendix 2.9 Patient Preferences Questionnaire Manual 
The Patient Preferences Questionnaire (PPQ) is a 51-item measure of 
patients’ preferences for various tasks and goals of psychotherapy and 
characteristics known to affect the therapeutic relationship. Each item is rated 
on a 6-point Likert scale, and describes something that can occur during 
various forms of psychotherapy.  
 
Item Origins 
The PPQ was developed from other measures, previously used to 
collect data on patients’ preferences, and adapted for use with older adults 
(OAs). It encompasses instructions and items from the Psychotherapy 
Preferences and Experiences Questionnaire (PEX, version P1; Clinton et al., 
1999). The PEX manual (Clinton & Sandell, 2014) describes it as a measure of 
patient preferences for and experiences of different aspects of various 
psychological therapies. Several versions of the PEX have been developed, 
implemented and validated since its inception in 1996 (Clinton & Sandell, 
2014). Version P1 of the PEX (PEX-P1; Clinton et al., 1999) has 50-items that 
are grouped into five sub-scales, which have been found to have good internal 
consistency (Cronbach’s alpha values range between 0.83 and 0.86; Clinton & 
Sandell, 2014). However, to the author’s knowledge, the PEX has not been 
used in studies with OAs. Additionally, Cooper and Norcross (2016) argued that 
despite its name, the PEX measures patients’ perceived helpfulness of each of 
its items, rather than their preference for these items. 
For these reasons, the PPQ also incorporates items from a list of 
psychotherapy tasks and outcomes, developed as part of another study of OAs’ 
preferences carried out within NHS Lanarkshire’s ‘Psychological Therapies for 
Older People’ (PTOP) service (Butrimaviciute, 2020). Butrimaviciute (2020) 
generated this list by identifying the key tasks involved in and expected 
outcomes of the psychological therapies recommended in the Older Adult 
Mental Health Matrix (NES, 2015), and the list was reviewed by PTOP staff 
(with experience of delivering psychological therapies to OAs presenting to 




PPQ Construction  
Items are grouped into four sub-sections: 
• Psychotherapy delivery (items 1 to 7) 
Items in this section assess patients’ preferences for different therapy 
delivery formats offered within PTOP (i.e. individual therapy; group therapy; 
support self-help and online CBT), and they were originally taken from 
Butrimaviciute’s (2020) study. However, the items were adapted to reflect 
changes to PTOP service provision during the COVID-19 pandemic, which 
meant therapy was increasingly delivered remotely via digital methods, such as 
telephone or video calls.  
• Therapist characteristics and approach (items 8 to 15)  
Items in this section relate to therapist characteristics and approach i.e. 
items that have the potential to influence the therapeutic relationship. Items 8 
and 9 were developed based on the Cooper-Norcross Inventory for 
Preferences (C-NIP; Cooper & Norcross, 2016). Similar to the PPQ, C-NIP was 
developed following review of existing measures of preferences (including the 
PEX). It is a 40-item measure of patient preferences, which dedicated 7-items 
to therapist characteristics, such as therapist gender, racial and religious 
background and sexual orientation. Within PTOP, and NHS Lanarkshire as a 
whole, it is unlikely that patient preferences for the latter three characteristics 
would be accommodated (for ethical reasons), and therefore they were not 
included in the PPQ. Pikus & Heavey (2008) found that some patients hold 
particular preferences regarding therapist gender, with the majority of their 
female participants preferring a female therapist. Although their male 
participants were less likely to state a preference for a particular therapist 
gender, those who did were also more likely to prefer a female. PTOP as a 
team has a mix of male and female therapists and may be able to 
accommodate patient preferences for therapist gender. Preference 
accommodation is associated with improved engagement and better outcomes 
(Swift et al., 2018), hence the inclusion of items 8 and 9. 
 Items 10 to 14 were developed from items included in the PEX, while 




reworded from “tell my story and be listened to and understood” to “Have a 
therapist who listens to me and tries to understand”, so that it fit the ‘Therapist 
characteristics and approach’ section of the PPQ as opposed to the 
‘Psychotherapy tasks’ section, as listening can be thought of as a non-specific 
factor in therapy, rather than a task. 
• Psychotherapy tasks (16 to 32)  
Items is this section were taken directly from the list of treatment tasks 
developed by Butrimaviciute (2020). They describe the main tasks (i.e. things 
the patient and/or therapist do in therapy) involved in the delivery of the 
psychological therapies recommended in The Matrix (NES, 2015) for treating 
mental health difficulties in an OA population. These therapies include CBT and 
ACT, which are both delivered by PTOP clinicians.   
• Psychotherapy outcomes (items 33 to 51)  
This section was included to elicit patient outcome preferences. Most of 
these items were developed in Butrimaviciute’s (2020) study, but items 34, 38 
and 40 were added during the COVID-19 pandemic to capture the potential 
impact of self-isolation on OAs’ outcome preferences. The items capture 
realistic outcomes that Matrix (NES, 2015) recommended psychological 
therapies can achieve within an OA population.   
COVID-19 related items 
The PPQ was updated to reflect changes to psychological service 
provision during COVID-19 and reflect the potential impact of self-isolation on 
OAs’ treatment and outcome preferences. Items 1 and 2 were added to explore 
OAs’ preferences for remote delivery options (i.e. telephone or video call 
appointments), as face-to-face appointments in a clinic setting (item 3) and 
home visits (item 4) are currently only provided to high risk clients who cannot 
engage remotely. Similarly, items 35, 39 and 41 were added to reflect the 
suspected impact of self-isolation on OAs’ outcome preferences. 
Question Structure 
The PPQ initially asks participants ‘What would you prefer if you were in 
psychotherapy?’ This question is an adaptation of the PEX-P1’s question: 




Sandell & Knutssön-Johns, 1999). It changes the questionnaires’ focus from 
“helpfulness beliefs” (Sandell et al., 2011) to preferences. The PPQ’s second 
question ‘What would you prefer to gain from psychotherapy?’ is asked prior to 
the ‘Psychotherapy outcomes’ sub-section, in order to gain an understanding of 
patients’ preferred treatment outcomes. Outcome preferences were not 
included in the PEX, or other measures of patient preferences, despite 
emerging evidence that they differ from the outcomes clinicians’ want to 
achieve for their patients (Eiring et al., 2015; Zimmermann et al., 2013).  
Similar to the PEX (Clinton & Sandell, 2014), there are two versions of 
the PPQ which allows it to be used flexibly across different time points (i.e. 
before, during and after therapy). Individual items are identical across the two 
versions, but the instructions and the object of ratings differ: 
• PPQ-1 can be administered before or during therapy and asks patients to 
rate the extent to which they would prefer different items. 
• PPQ-2 can be administered following the completion of a course of 
psychotherapy and asks patients to rate the extent to which they preferred 
different items.  
Please note that three additional questions have been added to the 
end of the PPQ for this feasibility study, which aim to gather data on the 
feasibility and acceptability of the questionnaire to the respondents.  
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Appendix 2.10 Clinicians Decision-Making Questionnaire (CDMQ) 
Participant ID Number:        
Date:          
Please read the following statements and rate the extent to which each factor 
influences your treatment selection. Place a cross (X) in box under the 
response alternative that suits best. Choose only one response for each 
statement. 
To what extent do the following factors influence your treatment 
selection? 














1.  Best practice guidelines (as 
outlined in the MATRIX, 
SIGN or NICE Guidelines) 
      
2.  Quantitative Research e.g. 
RCTs and meta-analytic 
evidence 
      
3.  Qualitative Research e.g. 
published case studies 
      
4.  Information obtained from 
conferences, training events 
and/or workshops 
      
5.  Your own clinical experience 
with clients 
      
6.  Your own experience of 
being a client 
      
7.  Supervision / consultation 
with others 
      
8.  Client preferences for tasks 
of therapy (e.g. cognitive 
restructuring; mindfulness; 
behaviour change) 
      
9.  Client preferences for format 
of therapy (e.g. group or 
individual, face-to-face or 
digital) 
      





Below is a list of factors that may influence your decision whether to consider 
client preferences (or not) when deciding on and selecting appropriate 
treatments. Please read each reason and rate how much each one influences 
whether you consider client preferences when selecting appropriate treatments. 
Place a cross (X) in box under the response alternative that suits best. Choose 
only one response for each statement. 
How much does this factor influence whether I consider client 
preferences when selecting appropriate treatments? 














11.  Type of presenting difficulty       
12.  The severity of the client’s 
presentation 
      
13.  Case complexity       
14.  Presence of co-morbidities       
15.  Client insight       
16.  Client’s previous experience 
of mental health support 
      
17.  The strength of client 
preferences 
      
18.  My preference for a 
particular treatment modality 
      
 
19. Were you required to make changes to the way you deliver psychological 
therapy in response to COVID-19 and the related government restrictions? 
 
Yes ☐  No ☐ 
 
20. If yes, do you think these changes (e.g. remote methods of delivery) will 
continue to be used with older adults following the relaxation of COVID-19 
restrictions? 
 
Yes ☐  No ☐ 
 
21. Have government imposed physical distancing measures made it more 
difficult for you to accommodate clients’ treatment preferences (i.e. their 
preferences for delivery format and/or tasks of therapy)? 
 




22. Have government imposed physical distancing measures made it more 
difficult for you to accommodate clients’ outcomes preferences (i.e. what 
they hope to gain from therapy)? 
 
Yes ☐  No ☐ 
 
Please answer the following questions about your experience of 
completing this questionnaire. Place a cross (X) in the box to the right of the 
response alternative that suits best. Choose only one response.  
 
23. The length of this questionnaire was:  
   
Too long ☐  Too short ☐  Just right ☐ 
24. The questions asked above seemed relevant to me and my circumstances: 
Yes ☐  No ☐  Sort of ☐ 
25. How easy was it to understand the questions and what was being asked of 
you? 





Appendix 2.11 Clinician Decision-Making Questionnaire Manual 
The Clinician Decision-Making Questionnaire (CDMQ) is an 22-item 
measure of factors that influence clinicians’ decision-making in psychotherapy. 
It was developed specifically for this study, based on methods used in previous 
research (Gyani et al., 2014; Safran et al., 2011; Stewart et al., 2018), and their 
findings.  The CDMQ has three distinct sub-sections, which are described 
below along with their encompassed items. 
 
Section 1: Factors that influence treatment selection (items 1 to 10) 
This section was adapted from the survey used in Morrow-Bradley & 
Elliot (1986), which asked clinicians to rate ‘the extent to which [different 
factors] had an impact on [clinicians’] practice’. Items 1 to 9 represent different 
factors that are known to influence clinicians’ decision-making when selecting 
treatment and were developed from questions asked in Safran et al. (2011) and 
Gyani et al. (2014), who also investigated factors that influence clinical 
decision-making. Clinicians are asked to read items 1 to 9 and rate the extent 
to which these factors influence their treatment selection, using a six-point 
scale that ranges from ‘not at all’ to ‘more than any other factor’. The 6-point 
scale used was taken from Morrow-Bradley & Elliot’s (1986) study.   
 
Section 2: Factors that influence clinicians’ decision whether to consider 
client preferences (items 11 to 18) 
Items in this section represent different factors that may influence 
clinicians’ decision whether to consider client preferences (or not) when 
deciding on and selecting appropriate treatments. Clinicians are asked to read 
items 11 to 18 and rate how much each factor influences this decision, using 
the six-point scale (outlined above).  
 
Section 3: Impact of COVID-19 of preference accommodation (items 19-
22) 
 Items in this section were added during the COVID-19 pandemic in 




(i.e. remote delivery of psychological therapies via digital methods). The items 
aim to understand whether COVID-19 and concomitant restrictions on face-to-
face contact with clients influenced Clinicians’ ability to accommodate client 
preferences. 
 
Please note that three additional questions have been added to the end of 
the CDMQ for this feasibility study, which aim to gather data on the 
feasibility and acceptability of the questionnaire to the respondents.  
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